Go to contentGo to menuGo to searchGo to the news list

MitoVasc : physiopathologie cardiovasculaire et mitochondriale


Main navigation

    Search

    Breadcrumb

    Publications before 2011

    Publications before 2011

    • Share this page on social networks
    • E-mail this page

      Send by mail


      Separated by coma
    • Print this page

    2010

    •  Guilluy C, Bregeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L, Henrion D, Scalbert E, Bril A, Torres RM, Offermanns S, Pacaud P, Loirand G. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nature Medicine 2010;16(2):183-90. (IF: 27.6)
    • Belin de Chantemele EJ, Vessieres E, Guihot AL, Toutain B, Loufrani L, Henrion D. Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries. Cardiovasc Res. 2010;81:788-96. (IF: 5.9) 270. 
    • Cousin M, Custaud MA, Baron-Menguy C, Toutain B, Dumont O, Guihot AL, Vessieres E, Subra JF, Henrion D, Loufrani L. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension.2010;55:109-115.(IF: 7.4)
    • Retailleau K, Belin de Chantemele EJ, Chanoine S, Guihot AL, Vessieres E, Toutain B, Faure S, Bagi Z, Loufrani L, Henrion D. Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries. Hypertension. 2010;55:339-344. (IF: 7.4)
    • Duge de Bernonville T, Guyot S, Paulin JP, Gaucher M, Loufrani L, Henrion D, Derbre S, Guilet D, Richomme P, Dat JF, Brisset MN. Dihydrochalcones: Implication in resistance to oxidative stress and bioactivities against advanced glycation end-products and vasoconstriction. Phytochemistry. 2010;71:443-52. (IF: 2.9)
    • Clere N, Corre I, Faure S, Guihot AL, Vessières E, Chalopin M, Morel A, Coqueret O, Hein L, Delneste Y, Paris F, Henrion D. Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. Int J Cancer, 2010; 127:2279-91. (IF: 4.7)
    • Baron-Menguy C, Toutain B, Cousin M, Dumont O, AL, Vessières E, Subra JF, Custaud MA, Loufrani L, Henrion D. Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries. Hypertens. Res. 2010 ; 33:857-66 (IF: 3.3)
    • Buschmann I, Pries A, Styp-Rekowska B, Hillmeister P, Shi Y, Duelsner A, Hoefer I, Gatzke N, Wang H, Lehmann K, Henrion D, Loufrani L, Hlushchuk R, Djonov V, le Noble F. Pulsatile shear and Gja5 (Connexin-40) modulate arterial identity and remodeling events during flow driven arteriogenesis. Development, 2010 ;137:2187-96. (IF: 6.8)
    • Koïtka A, Cao Z, Koh P, Watson AM, Sourris KC, Loufrani L, Soro-Paavonen A, Walther T, Woollard KJ, Jandeleit-Dahm KA, Cooper ME, Allen TJ. Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E- deficient mouse model of diabetes. Diabetologia.2010;53:584-92 (IF: 6.4)
    • Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L, Farman N, Lacolley P, Henrion D, Jaisser F. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J. 2010;24:2454-63 (IF: 7.1)
    • Lund N, Henrion D, Tiede P, Ziche M, Schunkert H, Ito WD. Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation. Biochem Biophys Res Commun.2010;395:401-6 (IF: 2.6)
    • Paumier A, Abraham P, Mahe G, Maugin E, Enon B, Leftheriotis G, Picquet J. Functional outcome of hypogastric revascularisation for prevention of buttock claudication in patients with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 2010;39(3):323-9. (IF: 3.007)
    • Hureaux J, Lagarce F, Gagnadoux F, Rousselet MC, Moal V, Urban T, Benoit JP. Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice. Pharm Res2010;27(3):421-30. (IF: 3.287)
    • LeFaucheur A, Noury-Desvaux B, Mahe G, Sauvaget T, Saumet JL, Leftheriotis G, Abraham P. Variability and short-term determinants of walking capacity in patients with intermittent claudication. J Vasc Surg2010;51(4):886-892. (IF: 3.770)
    • Mahe G, Abraham P, Zeenny M, Bruneau A, Vielle B, Leftheriotis G. Objective determination of the predefined duration of a constant-load diagnostic tests in arterial claudication. J Vasc Surg 2010;51(4):863-868. (IF: 3.770)
    • Debbabi H, Bonnin P, Ducluzeau PH, Leftheriotis G, Levy BI. Noninvasive Assessment of Endothelial Function in the Skin Microcirculation. Am J Hypertens 2010. (IF: 3.122)
    • Sauvet F, Leftheriotis G, Gomez-Merino D, Langrume C, Drogou C, Van Beers P, Bourrilhon C, Florence G, Chennaoui M. Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol2010;108(1):68-75. (IF: 3.658)
    • Costrop LM, Vanakker OO, Van Laer L, Le Saux O, Martin L, Chassaing N, Guerra D, Pasquali-Ronchetti I, Coucke PJ, De Paepe A. Novel deletions causing pseudoxanthoma elasticum underscore the genomic instability of the ABCC6 region. J Hum Genet 2010;55(2):112-7. (IF: 2.4)
    • Le Boulanger G, Labreze C, Croue A, Schurgers LJ, Chassaing N, Wittkampf T, Rutsch F, Martin L. An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am J Med Genet A 2010;152A:118-23. (IF: 2.6)
    • Vanakker OM, Martin L, Schurgers LJ, Quaglino D, Costrop L, Vermeer C, Pasquali- Ronchetti I, Coucke PJ, De Paepe A. Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. Lab Invest. 2010 Apr 5. [Epub ahead of print] (IF: 4.6)
    • Guillet V, Gueguen N, Verny C, Ferre M, Homedan C, Loiseau D, Procaccio V, Amati- Bonneau P, Bonneau D, Reynier P, Chevrollier A. Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease. Neurogenetics (2010) 11 (1):127-33. (IF: 3.0)
    • Cramer S, Sampat A, Haske-Palomino M, Nguyen S, Procaccio V, Hermanowicz N; Increased prevalence of val66met BDNF genotype among subjects with cervical dystonia; Neuroscience Letters (2010) 1; 468:42-45.(IF: 2.2)
    • Guillet V, Chevrollier A, Cassereau J, Letournel F, Gueguen N, Richard L, Desquiret V, Verny C, Procaccio V, Amati-Bonneau P, Reynier P, Bonneau D. Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity. Mitochondrion (2010) 10 (2): 115-124. (IF: 4.3)
    • Su H, Fan W, Coskun PE, Vesa J, Gold JA, Jiang YH, Potluri P, Procaccio V, Acab A, Weiss JH, Wallace DC, Kimonis VE. Mitochondrial dysfunction in CA1 hippocampal neurons of the Ube3a deficient mouse model for Angelman syndrome. Neuroscience Letters (2010) press (IF: 2.2)
    • McHughen S, Kleim J, Kleim E, Procaccio V, Cramer S. BDNF val 66 met polymorphism and short-term experience-dependent plasticity in the human brain. Cerebral Cortex (2010), in press (IF: 5.9)
    • Kucharczyk R, Ezkurdia N, Couplan E, Procaccio V, Ackerman SH, Blondel M, di Rago JP. Consequences on yeast mitochondrial ATP synthase of the pathogenic T9176C mutation of human mitochondrial DNA.Biochimica et Biophysica Acta (2010) 1797(6-7):1105-12 (IF: 2.8)
    • Freidja ML, Vessières E, Desquiret V, Guihot AL, Toutain B , Jardel A, ProcaccioV, Daniel Henrion D. Heme oxygenase-1 induction restores high-blood-flow-dependent remodelling and endothelial function in mesenteric arteries of old rats J. Hypertens, in press. (IF: 5.1)
    • Duong Van Huyen J.P., Vessiere E., Perret C., Troise A., Prince S., Guihot A.L., Barbry P., Henrion D., Bruneval P., Laurent S., Lelièvre-Pégorier M., Fassot CIn utero exposure to maternal diabetes impairs vascular expression of prostacyclin receptor in rats offspring. Diabetes (2010) 59(10):2597-602 (IF: 8.4)
    • Kremer H, Baron-Menguy C, Tesse A, Gallois Y, Mercat A, Henrion D, Andriantsitohaina R, Asfar P; ferhat meziani F. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: A concentration dependent properties. Critical Care Medicine, in press (IF : 6.6)
    • Navasiolava NM, Dignat-George F, Sabatier F, Larina IM, Demiot C, Fortrat JO, Gauquelin- Koch G, Kozlovskaya IB, Custaud MA. Enforced Physical Inactivity Increases Endothelial Microparticle Levels in Healthy Volunteers.Am J Physiol.(2010) 299(2):H248-56 (IF: 3.6)
    • Ganster F, Burban M, de La Bourdonnaye M, Fizanne L, Douay O, Loufrani L, Mercat A, Cales P, Radermacher P, Henrion D, Asfar P, Meziani F. Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care. 2010;14:R165. (IF: 4.6)
    • Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC. Circulating Microparticles from Pulmonary Hypertensive Rats Induce Endothelial Dysfunction. Am J Respir Crit Care Med. 2010 Mar 25. (IF: 9.8)
    • Chalopin M, Tesse A, Martínez MC, Rognan D, Arnal JF, Andriantsitohaina R. Estrogen receptor alpha as a key target of red wine polyphenols action on the endothelium. PLoS One. 2010;5(1):e8554. (IF :4.3)
    • Priou P, Gagnadoux F, Tesse A, Mastronardi ML, Agouni A, Meslier N, Racineux JL,
    • Martinez MC, Trzepizur W, Andriantsitohaina R. Endothelial Dysfunction and Circulating Microparticles from Patients with Obstructive Sleep Apnea. Am J Pathol. (2010) 177(2):974- 83 (IF: 5.7)
    • Osterstock G, Escobar P, Mitutsova V, Gouty-Colomer LA, Fontanaud P, Molino F, Fehrehtz JA, Carmignac D, Martinez J, Guérineau NC, Robinson ICAF, Mollard P, Mery PF. Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS One. 2010;5:e9159. (IF: 4.3)
    • Colomer C, Olivos-Oré LA, Vincent A, McIntosh JM, Artalejo AR, Guérineau NC. Functional characterization of alpha9-containing cholinergic nicotinic receptors in the rat adrenal medulla: implication in stress-induced functional plasticity. J Neurosci. 2010;30:6732-6742. (IF: 7.2)
    • Guérineau NC, Desarménien MG. Developmental and stress-induced remodeling of cell-cell communication in the adrenal medullary tissue. Cell. Mol. Neurobiol., in press. (IF: 2.1)
    • Milea D, Sander B, Wegener M, Jensen H, Kjer B, Jorgensen TM, Lund-Andersen H, Larsen M. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol 2010 ; 88, 342-346. (IF:1.9)
    • Wegener, M., Prause, J.U., Thygesen, J., Milea, D., 2010. Arachnoid cyst causing an optic neuropathy in neurofibromatosis 1. Acta Ophthalmol 88, 497-499. (IF:1.9)
    • Kawasaki, A., Herbst, K., Sander, B., Milea, D., 2010. Selective wavelength pupillometry in Leber hereditary optic neuropathy. Clin Experiment Ophthalmol 38, 322-324. (IF:1.347)
    • Milea, D., Amati-Bonneau, P., Reynier, P., Bonneau, D., 2010. Genetically determined optic neuropathies.Curr Opin Neurol 23, 24-28. (IF:5.5)
    • Sandfeld, L., Petersen, E., Sousa, S., Laessoe, M., Milea, D., 2010. Bilateral papillitis in ocular toxoplasmosis.Eye (Lond) 24, 188-189. (IF:2.3)
    • Kiilgaard JF, Milea D, et al. Cerebral Migration of Intraocular Silicone Oil : an MRI study. Acta Ophthalmol2010, in press. (IF:1.9)
    • Giraudet S, Milea D et al. Never too old to Harbour a Young man’s disease? BrJOphthalmol. 2010, in press.(IF:2.8)
    • La Morgia C, Milea D et al. Melanopsin-containing retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain, 2010, in press (IF:9.6)
    • Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T: Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 2010 ahead of print (IF:6.418)
    • Coutant R, Biette-Demeneix E, Bouvattier C, Bouhours N, Gatelais F, Rouleau S, Dufresne S, Lahlou N. Baseline Inhibin B and Anti-Mullerian Hormone Measurements for Diagnosis of Hypogonadotropic Hypogonadism (HH) in Boys with Delayed Puberty. 2010 J Clin Endocrinol Metab in press. (IF:6.325)
    • Priou-Guesdon M, Malinge MC, Augusto JF, Rodien PSubra JFBonneau D, Rohmer V. Hypochloremia and hyponatremia as the initial presentation of cystic fibrosis in three adults. Ann Endocrinol (Paris) 2010; 71: 46-50. (IF:3.791)
    • Ravaud A, De la Fouchardière C, Asselineau J, Delord JP, Do Cao C, Nicolli P, Rodien P, Klein M, Catargi B. Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU.Oncologist2010; 15: 212-213. (IF:6.630)
    • Rodien P, Beau I, Vasseur C. Ovarian hyperstimulation syndrome (OHSS) due to mutations in the follicle-stimulating hormone receptor. Ann Endocrinol (Paris). 2010 Apr 1. [Epub ahead of print] (IF:0.446)
    • Rodien P. No heresy, rather hysteresis; reply to: The TSH-free thyroxine relationship: logarithmic-linear or error function? Eur J Endocrinol. 2010 Aug 26. [Epub ahead of print] (IF:3.791)
    • Masson I., Fassot C., Zidi M. Finite dynamic deformations of a hyperelastic, anisotropic, incompressible and prestressed tube. European Journal of Mechanics A/Solids, 2010 ; 29 : 523-29. (IF:1.674)
    • Duong Van Huyen J.P., Vessiere E., Perret C., Troise A., Prince S., Guihot A.L., Barbry P., Henrion D., Bruneval P., Laurent S., Lelièvre-Pégorier M., Fassot CIn utero exposure to maternal diabetes impairs vascular expression of prostacyclin receptor in rats offspring. Diabetes, (2010) 59(10):2597-602 (IF:8.398)
    • Casasnovas C, Banchs I, Cassereau J, Gueguen N, Chevrollier A, Martínez-Matos JA, Bonneau D, Volpini V. Phenotypic Spectrum of MFN2 Mutations in the Spanish Population. J Med Genet 2010;47:249-56. (IF: 5.7)
    • Guillet V, Gueguen N, Verny C, Ferre M, Homedan C, Loiseau D, Procaccio V, Amati- Bonneau P, Bonneau D, Reynier P, Chevrollier A. Adenine nucleotide translocase is involved in a mitochondrial coupling defect in mfn2-related Charcot-Marie-Tooth type 2A disease. Neurogenetics 2010;11:127-33. (IF: 3.0)
    • Guillet V, Chevrollier A, Cassereau J, Letournel F, Gueguen N, Richard L, Verny C, Procaccio V, Amati-Bonneau P, Reynier P, Bonneau D. Etambutol-induced optic neuropathy liked to OPA1 mutation and mitochondrial toxicity. Mitochondrion 2010;10:115-24. (IF: 4.3)
    • Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M , Toscano A, Musumeci O, Valentino ML, Caporali L, Lamperti C, Tallaksen CM, Duffey P, Miller J, Whittaker RG, Baker MR, Jackson MJ, Clarke MP, Dhillon B, Czermin B, Stewart JD, Hudson G, Reynier P, Bonneau D, Marques WJr, Lenaers G, McFarland R, Taylor RW, Turnbull DM, Votruba M, Zeviani M, Carelli V, Bindoff LA, Horvath R, Amati-Bonneau P, Chinnery PF. Multi-system neurological disease is common in patients with OPA1 mutations. Brain2010;133:771-86. (IF: 9.6)
    • Lamirel C, Cassereau J, Cochereau I, Vignal-Clermont C, Pajot O, Tanguy JY, Zanlonghi X, Reynier P, Amati-Bonneau P, Dubas F, Bonneau D, Verny C. Papilloedema and MRI enhancement of the prechiasmal optic nerve at the acute stage of Leber hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 2010;81:578-80.(IF: 4.6)
    • Giraudet S, Lamirel C, Amati-Bonneau P, Reynier P, Bonneau D, Miléa D, Cochereau I. Never too old to harbour a young man’s disease? Brit J Ophthalmol 2010, In Press. (IF: 2.9)
    • Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P, Guichet A, Barth M, Charollais A, Journel H, Auvin S, Boucher C, Kerckaert JP, David V, Manouvrier-Hanu S, Saugier-Veber P, Frébourg T, Dubourg C, Andrieux J, Bonneau D. MEF2C haploinsufficiency caused either by microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet 2010;47:22-29. (IF: 5.7)
    • Barth M, Ottolenghi C, Valayannopoulos V, Hubert L, de Keyzer Y, Chretien D, Serre V, Gobin S, Vassault A, Romano S, Ricquier D, Boddaert N, Duran M, Brivet M, Munnich A, Rabier D, de Lonlay P. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. J Inherit Metab Dis In press. (IF : 2.7)
    • Alayannopoulos V, Haudry C, Serre V, Barth MBoddaert N, Arnoux JB, Cormier-Daire V, Rio M, Rabier D, Vassault A, Munnich A, Bonnefont JP, de Lonlay P, Rötig A, Lebre AS. New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria. Mitochondrion 2010;10:335-41. (IF : 4.3)
    • Muller J, Stoetzel C, Vincent MC, Leitch CC, Laurier V, Danse JM, Hellé S, Marion V, Bennouna-Greene V, Vicaire S, Megarbane A, Kaplan J, Drouin-Garraud V, Hamdani M, Sigaudy S, Francannet C, Roume J, Bitoun P, Goldenberg A, Philip N, Odent S, Green J, Cossée M, Davis EE, Katsanis N, Bonneau D, Verloes A, Poch O, Mandel JL, Dollfus H. Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease. Hum Genet 2010;127:583-93. (IF: 4)
    • El Chehadeh S, Aral B, Gigot N, Thauvin-Robinet C, Donzel A, Delrue MA, Lacombe D, David A, Burglen L, Philip N, Moncla A, Cormier-Daire V, Rio M, Edery P, Verloes A, Bonneau D, Affenjar A, Jacquette A, Heron D, Sarda P, Pinson L, Doray B, Vigneron J, Leheu B, Frances-Guidet AM, Dienne G, Holder M, Masurel-Paulet A, Huet F, Teyssier JR, Faivre L. Search for the best indicators for the presence of a VPS13B gene mutation and confirmation of diagnostic criteria in a series of 34 patients genotyped for suspected Cohen syndrome. J Med Genet 2010; 47(8):549-53 (IF: 5.7)
    • Casasnovas C, Banchs I, Cassereau J, Gueguen N, Chevrollier A, Martínez-Matos JA, Bonneau D, Volpini V. Phenotypic spectrum of MFN2 mutations in the Spanish population. J Med Genet. 2010, 47(4):249-56 (IF: 5.7)
    • Alao MJ, Bonneau D, Holder-Espinasse M, Goizet C, Manouvrier-Hanu S, Mezel A, Petit F, Subtil D, Magdelaine C, Lacombe D. Oculo-dento-digital dysplasia: Report on three families with novel GJA1 mutations and prenatal presentation. Eur J Med Genet 2010;53:19-22. (IF: 5.7)
    • Alazami AM, Schneider S, Bonneau D, Pasquier L, de Kerdanet M, Degos B, Goh E, Alkuraya FS. C2orf37 Mutational Spectrum in Woodhouse-Sakati Syndrome Patients. Clin Genet 2010, 78(6):585-90. (IF: 3.2)
    • Mirebeau-Prunier D, LePennec S, Jacques C, Gueguen N, Poirier J, Malthiery Y, Savagner F. Estrogen-related receptor alpha and PGC-1-related coactivator constitute a novel complex mediating the biogenesis of functional mitochondria. FEBS J 2010;277:713-725. (IF: 3.1)
    • Bayet-Robert M, Loiseau D, Rio P, Demidem A, Barthomeuf C, Stepien G, Morvan D. Quantitative two-dimensional HRMAS 1H-NMR spectroscopy-based metabolite profiling of human cancer cell lines and response to chemotherapy. Magn Reson Med 2010;63(5):1172- 83. (IF:3.4)
    • Tosch V, Vasli N, Kretz C, Nicot AS, Gasnier C, Dondaine N, Oriot D, Barth M, Puissant H, Romero NB, Bönnemann CG, Heller B, Duval G, Biancalana V, Laporte J.Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations. Neuromuscul Disord 2010; 20:375-81. (IF : 4.3)
    • Autret A, Roux , Rimbaux-Lepage S, Valade D, Debiais S, Allain H, Hinault P, de Bray JM, Dubas F, Verny C, Feve JM, Magne C, Merienne JM, Neau JP, Pinel JF, Pouyet A, Schuermans P, Verret JM. Psychopathology and quality of life burden in chronic daily headache: influence of migraine symptoms. J Headache Pain2010;11:247-53. (IF: 1.9)
    • C Verny, N Guegen, V Desquiret, A Prundean, F Dubas, A Chevrollier, P Amati-Bonneau, D Bonneau, P Reynier, V Procaccio. Hereditary spastic paraplegia due to a mitochondrial ATP6 gene point mutation Mitochondrion2010; In press (IF: 4.3)
    • Ghaboura N, Tamareille S, Ducluzeau PH, Grimaud L, Loufrani L, Croué A, Tourmen Y, Henrion D, Furber A, Prunier F. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling. Basic Res Cardiol. 2010 Oct 28. [Epub ahead of print] (IF: 5.407)
    • Vessieres E, Belin de Chantemèle EJ, Toutain B, Guihot AL, Jardel A, Loufrani L, Henrion D. Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese Zucker rat mesenteric arteries Frontiers in Vascular Physiology. Published on 02 November 2010.
    • Belizna C, Henrion D, Beucher A, Lavigne C, Ghaali A, Lévesque H. Anti-Ku antibodies: Clinical, genetic and diagnostic insights. Autoimmun Rev.(2010) 9(10):691-4 (IF: 5.4)
    • Kremer H; Baron-Menguy C, Tesse A, Gallois Y, Mercat A, Henrion D, Andriantsitohaina R, Asfar P; ferhat meziani F. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: A concentration dependent properties. Critical Care Medicine, in press
    • Freidja ML, Vessières E, Desquiret V, Guihot AL, Toutain B, Jardel A, Procaccio V, Henrion D. Heme oxygenase-1 induction restores high-blood-flow-dependent remodelling and endothelial function in mesenteric arteries of old rats J. Hypertens, in press (IF: 5.132)
    • Schaefer E, Durand M, Stoetzel C, Doray B, Viville B, Hellé S, Danse JM, Hamel C, Bitoun P, Goldenberg A, Finck S, Faivre L, Sigaudy S, Holder M, Vincent MC, Marion V, Bonneau D, Verloes A, Nisand I, Mandel JL, Dollfus H. Molecular diagnosis reveals genetic heterogeneity for the overlapping MKKS and BBS phenotypes.European Journal of Medical Genetics 2010, in press
    • . Krug P, Morinière V, Marlin S, Koubi V, Gabriel HD, Colin E, Bonneau D, Salomon R, Antignac CO, Heidet L. Mutation screening of the EYA1, SIX1 and SIX5 genes in a large cohort of patients harboring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations. Human Mutation 2010, in press
    • Alazami AM, Schneider S, Bonneau D, Pasquier L, De Kerdanet M, Degos B, Goh E, FS. Alkuraya FS. C2orf37 Mutational Spectrum in Woodhouse-Sakati Syndrome Patients. Clinical Genetics. 2010, in press
    • Alao MJ, Bonneau D, Holder-Espinasse M, Goizet C, Manouvrier-Hanu S, Mezel A, Petit F, Subtil D, Magdelaine C, Lacombe D. Oculo-dento-digital dysplasia: Lack of genotype- phenotype correlation for GJA1 mutations and usefulness of neuro-imaging. European Journal of Medical Genetics, 2010, in press
    • El Chehadeh S, Aral B, Gigot N, Thauvin-Robinet C, Donzel A, Delrue MA, Lacombe D, David A, Burglen L, Philip N, Moncla A, Cormier-Daire V, Rio M, Edery P, Verloes A, Bonneau D, Affenja A, Jacquette A, Heron D, Sarda P, Pinson L, Doray B, Vigneron J, Leheup B, Frances-Guidet AM, Dienne G, Holder M, Masurel-Paulet A, Huet F, Teyssier JR, Faivre L. Search for the best indicators for the presence of a VPS13B gene mutation and confirmation of diagnostic criteria in a series of 34 patients genotyped for suspected Cohen syndrome. Journal of Medical Genetics 2010;47:549-553.
    • Muller J, Stoetzel C, Vincent MC, Leitch CC, Laurier V, Danse JM, Hellé S, Marion V, Bennouna-Greene V, Vicaire S, Megarbane A, Kaplan J, Drouin-Garraud V, Hamdani M, Sigaudy S, Francannet C, Roume J, Bitoun P, Goldenberg A, Philip N, Odent S, Green J, Cossée M, Davis EE, Katsanis N, Bonneau D, Verloes A, Poch O, Mandel JL, Dollfus H. Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease. Human Genetics 2010 ;127 :583-593.
    • Alao MJ, Bonneau D, Holder-Espinasse M, Goizet C, Manouvrier-Hanu S, Mezel A, Petit F, Subtil D, Magdelaine C, Lacombe D. Oculo-dento-digital dysplasia: Report on three families with novel GJA1 mutations and prenatal presentation. European Journal of Medical Genetics 2010;53:19-22.
    • Marelli C, Amati-Bonneau P, Reynier P, Layet V, Layet A, Stevanin G, Brissaud E, Bonneau D, Durr A, Brice A. Heterozygous OPA1 mutations in Behr syndrome. Brain. 2010 [Epub ahead of print]. (IF: 9.603)
    • Elachouri G, Vidoni S, Zanna C, Pattyn A, Boukhaddaoui H, Gaget K, Yu-Wai-Man P, Gasparre G, Sarzi E, Delettre C, Olichon A, Loiseau D, Reynier P, Chinnery PF, Rotig A, Carelli V, Hamel CP, Rugolo M, Lenaers G. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res. [Epub ahead of print] (IF:10.176)
    • Chevrollier A, Loiseau D, Reynier P, Stepien G. Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism. Biochim Biophys Acta. [Epub ahead of print].
    • Cassereau J, Chevrollier A, Gueguen N, Desquiret V, Verny C, Nicolas G, Dubas F, Amati- Bonneau P, Reynier P , Bonneau D, Procaccio         V. Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations. Exp Neurol. [Epub ahead of print]. (IF: 3.974)
    • Verny C, Guegen N, Desquiret V, Chevrollier A, Prundean A, Dubas F, Cassereau J, Ferre M, Amati-Bonneau P, Bonneau D, Reynier P, Procaccio V. Hereditary spastic paraplegia- like disorder due to a mitochondrial ATP6 gene point mutation. Mitochondrion. 2010 [Epub ahead of print]. (IF: 4.262)
    • Cassereau J, Casasnovas C , Guegen N, Malinge MC, GuilletV, Reynier P, Bonneau D, Amati-Bonneau P, Banchs I, Volpini V, Procaccio V, Chevrollier A. Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a CMT patient. Neurology Manuscrit in press
    • Poole J, Procaccio V, Brandon M, Merrick G, Wallace DC. Multiplex Analysis of Mitochondrial DNA Pathogenic and Polymorphic Sequence Variants. Biological Chemistry 391(10):1115-30. (IF: 3.035)
    • Skau M, Milea D, Sander B, Wegener M, Jensen R. OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2010 [Epub ahead of print]. (IF: 1.77)
    • Ghaboura N, Tamareille S, Ducluzeau PH, Grimaud L, Loufrani L, Croué A, Tourmen Y, Henrion D, Furber A, Prunier F. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling. Basic Res Cardiol. 2010 Oct 28. [Epub ahead of print] (IF: 5.407)
    • Vessieres E, Belin de Chantemèle EJ, Toutain B, Guihot AL, Jardel A, Loufrani L, Henrion D. Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese Zucker rat mesenteric arteries Frontiers in Vascular Physiology. Published on 02 November 2010
    • Belizna C, Henrion D, Beucher A, Lavigne C, Ghaali A, Lévesque H. Anti-Ku antibodies: Clinical, genetic and diagnostic insights. Autoimmun Rev.(2010) 9(10):691-4 (IF: 5.4)
    • Rey J., Devillé J., and Chabbert M. (2010) Structural determinants stabilizing helical distortions related to proline. J. Struct. Biol. 2010 ; 171: 266-76 (IF: 3.7)
    • Kremer H, Baron-Menguy C, Tesse A, Gallois Y, Mercat A, Henrion D, Andriantsitohaina R, Asfar P, ferhat meziani F. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: A concentration dependent properties. Critical Care Medicine, in press (IF: 6.594)
    • Martin L, Douet V, VanWart CM, Heller MB, Le Saux O. A Mouse Model of beta- Thalassemia Shows a Liver-Specific : Downregulation of Abcc6 Expression. The American Journal of Pathology, in press.

    2009

    • Sharif-Naeini R, Folgering JH, Bichet D, Duprat F, Lauritzen I, Arhatte M, Jodar M, Dedman A, Chatelain FC, Schulte U, Retailleau K, Loufrani L, Patel A, Sachs F, Delmas P, Peters DJ, Honoré E. Polycystin-1 and -2 dosage regulates pressure sensing. Cell. 2009 30;139:587-96 (IF: 31.0)
    • Belin de Chantemele EJ, Vessieres E, Dumont O, Guihot AL, Toutain B, Loufrani L, Henrion D. Reactive oxygen species are necessary for high flow (shear stress)-induced diameter enlargement of rat resistance arteries.Microcirculation. 2009;16:391-402. (IF: 2.5)
    • Belin de Chantemele EJ, Vessieres E, Guihot AL, Toutain B, Maquignau M, Loufrani L, Henrion D. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc Res. 2009;81:788-796. (IF: 5.9)
    • Mortaza S, Martinez MC, Baron-Menguy C, Burban M, de la Bourdonnaye M, Fizanne L, Pierrot M, Cales P, Henrion D, Andriantsitohaina R, Mercat A, Asfar P, Meziani F. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit Care Med. 2009;37:2045-2050. (IF: 6.6)
    • Rutkai I, Feher A, Erdei N, Henrion D, Papp Z, Edes I, Koller A, Kaley G, Bagi Z. Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes. Cardiovasc Res. 2009;83:148-154. (IF: 5.9)
    • Sennoun N, Baron-Menguy C, Burban M, Lecompte T, Andriantsitohaina R, Henrion D, Mercat A, Asfar P, Levy B, Meziani F. Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries. Am J Physiol. 2009;297:H277-282. (IF: 3.6)
    • Tamareille S, Ghaboura N, Treguer F, Khachman D, Croue A, Henrion D, Furber A, Prunier F. Myocardial reperfusion injury management: Erythropoietin compared with postconditioning. Am J Physiol. 2009; 297:H2035-43. (IF: 3.6)
    • Otte LA, Bell KS, Loufrani L, Yeh JC, Melchior B, Dao DN, Stevens HY, White CR, Frangos JA. Rapid changes in shear stress induce dissociation of a G alpha(q/11)-platelet endothelial cell adhesion molecule-1 complex. J Physiol. 2009 15;2365-73 (IF:4.6)
    • Navasiolava N, Custaud MA. What are the future top priority questions in cardiovascular research and what new hardware needs to be developed? Respir Physiol Neurobiol. 2009;169 Suppl 1:S73-4. (IF: 2.0)
    • Coupé M, Fortrat JO, Larina I, Gauquelin-Koch G, Gharib C, Custaud MA. Cardiovascular deconditioning: From autonomic nervous system to microvascular dysfunctions. Respir Physiol Neurobiol. 2009;169 Suppl 1:S10-2. (IF: 2.0)
    • Thiriez G, Bouhaddi M, Mourot L, Nobili F, Fortrat JO, Menget A, Franco P, Regnard J. Heart rate variability in preterm infants and maternal smoking during pregnancy. Clin Auton Res. 2009;19:149-56. (IF: 1.5)
    • Devillé J, Rey J, Chabbert M. An indel in transmembrane helix 2 helps to trace molecular evolution of class A G-protein coupled receptors. J. Mol. Evol., 2009;68: 475-89. (IF: 2.8)
    • Biotteau E, Mahe G, Rousseau P, Leftheriotis G, Abraham P. Transcutaneous oxygen pressure measurements in diabetic and non-diabetic patients clinically suspected of severe limb ischemia: a matched paired retrospective analysis. Int Angiol 2009;28(6):479-83. (IF: 1.418)
    • Mahe G, Leftheriotis G, Picquet J, Jaquinandi V, Saumet JL, Abraham P. A normal penile pressure cannot rule out the presence of lesions on the arteries supplying the hypogastric circulation in patients with arterial claudication. Vasc Med 2009;14(4):331-8. (IF: 1.736)
    • Bruneau A, Le Faucheur A, Mahe G, Vielle B, Leftheriotis G, Abraham P. Endofibrosis in athletes: is a simple bedside exercise helpful or sufficient for the diagnosis? Clin J Sport Med 2009;19(4):282-6. (IF: 1.595)
    • Rousseau P, Mahe G, Fromy B, Ducluzeau PH, Saumet JL, Abraham P. Axon-reflex cutaneous vasodilatation is impaired in type 2 diabetic patients receiving chronic low-dose aspirin. Microvasc Res 2009;78(2):218-23.(IF: 3.000)
    • Humeau A, Buard B, Chapeau-Blondeau F, Rousseau D, Mahe G, Abraham P. Multifractal analysis of central (electrocardiography) and peripheral (laser Doppler flowmetry) cardiovascular time series from healthy human subjects. Physiol Meas 2009;30(7):617-29. (IF: 1.691)
    • Trzepizur W, Gagnadoux F, Abraham P, Rousseau P, Meslier N, Saumet JL, Racineux JL. Microvascular endothelial function in obstructive sleep apnea: Impact of continuous positive airway pressure and mandibular advancement. Sleep Med 2009;10(7):746-52. (IF: 3.163)
    • Mahe G, Chevalier C, Caroff J, Leftheriotis G. So-called lateral meniscal cyst. J Rheumatol2009;36(10):2317. (IF: 3.282)
    • Gagnadoux F, Fleury B, Vielle B, Petelle B, Meslier N, N'Guyen XL, Trzepizur W, Racineux JL. Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur Respir J 2009;34(4):914-20.(IF: 3.061)
    • Hureaux J, Lagarce F, Gagnadoux F, Vecellio L, Clavreul A, Roger E, Kempf M, Racineux JL, Diot P, Benoit JP, Urban T. Lipid nanocapsules: ready-to-use nanovectors for the aérosol delivery of paclitaxel. Eur J Pharm Biopharm 2009;73:239-46. (IF: 3,344)
    • Hureaux J, Lagarce F, Gagnadoux F, Clavreul A, Benoit JP, Urban T. The adaptation of lipid nanocapsule formulations for blood administration in animals. Int J Pharm 2009;379(2):266-9. (IF: 3.061)
    • Picquet J, Blin V, Dussaussoy C, Jousset Y, Papon X, Enon B. Surgical reconstruction of the superior vena cava system: indications and results. Surgery 2009;145:93-9. (IF: 3,389)
    • Collette M, Leftheriotis G, Humeau A. Modeling and interpretation of the bioelectrical impedance signal for the determination of the local arterial stiffness. Med Phys 2009;36:4340-8. (IF: 3.871)
    • Naouri M, Boisseau C, Bonicel P, Daudon P, Bonneau D, Chassaing N, Martin L. Manifestations of pseudoxanthoma elasticum in childhood. Br J Dermatol 2009;161(3):635-9. (IF: 3.5)
    • Brandon M, Ruiz-Pesini E, Mishmar D, Procaccio V., Lott M, Cuong Nguyen K, Spolim S, Patil U, Baldi P, Wallace DC. MITOMASTER – A Bioinformatics Tool For the Analysis of Mitochondrial DNA Sequences. Human Mutation(2009) 30: 1-6. (IF: 7.0)
    • Potluri P, Davila A, Ruiz-Pesini E, Mishmar M, O’Hearn S, Hancock S, Simon M, Scheffler I, Wallace DC, Procaccio V. A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific Neurodegenerative Disease. Molecular Genetics and Metabolism. (2009) 96 189-195. (IF: 2.6)
    • Cassereau J, Chevrollier A, Gueguen N, Malinge MC, Letournel F, Nicolas G, Vallat JM, Verny C, Dubas F, Procaccio V, Amati-Bonneau P, Bonneau D, Reynier P. Mitochondrial Complex I Deficiency in GDAP1-related Autosomal Dominant Charcot-Marie Tooth Disease (CMT2K); Neurogenetics, (2009) 10(2):145-50. (IF: 3.0)
    • NochezY,ArseneS,GueguenN,ChevrollierA,FerréM,GuilletV,DesquiretV,ToutainA, Bonneau D, Procaccio V, Amati-Bonneau P, Pisella PJ, Reynier P. Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect. Molecular Vision, (2009)15:598-608. (IF: 2.4)
    • Ferre M, Reynier P, Chevrollier A, Dollfus H, Milea D, Ayuso C, Defoort S, Vignal C, Zanlonghi X, Charlin JC, Kaplan J, Odent S, Hamel C, Procaccio V, Bonneau D, Amati- Bonneau P. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 Novel OPA1 mutations. Human Mutation (2009) 30(7):E692-E705. (IF: 7.0)
    • Bannwarth S, Procaccio V, Paquis-Flucklinger V. Rapid identification of unknown heteroplasmic mitochondrial DNA mutations with mismatch-specific surveyor nuclease. Methods Molecular Biology. (2009);554:301-13.(IF: 1.8)
    • Fragaki, K., Procaccio V, Bannwarth S, Serre V, O’Hearn S, Potluri P, Augé G, Casagrande F, Caruba C, Lambert JC, Paquis-Flucklinger V. New homoplasmic mutation in the mitochondrially encoded cytochrome b gene leads to a fatal neonatal disease. Mitochondrion (2009) 9(5):346-52. (IF: 4.3)
    • Pricci M, Bourget JM, Robitaille H, Porro C, Soleti R, Mostefai HA, Auger FA, Martinez MC, Andriantsitohaina R, Germain L. Applications of human tissue-engineered blood vessel models to study the effects of shed membrane microparticles from T-lymphocytes on vascular function. Tissue Eng Part A. 2009;15(1):137-45. (IF: 4.7)
    • Rezzani R, Tengattini S, Bonomini F, Filippini F, Pechánová O, Bianchi R, Andriantsitohaina R. Red wine polyphenols prevent cyclosporine-induced nephrotoxicity at the level of the intrinsic apoptotic pathway.Physiol Res. 2009;58(4):511-9. (IF: 1.6)
    • Soleti R, Benameur T, Porro C, Panaro MA, Andriantsitohaina R, Martínez MC. Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors.Carcinogenesis. 2009;30(4):580-8. (IF: 4.9)
    • Sennoun N, Meziani F, Dessebe O, Cattan V, Collin S, Montemont C, Gibot S, Asfar P, Ramaroson A, Regnault V, Slama M, Lecompte T, Lacolley P, Levy B. Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress. Crit Care Med.2009;37(1):246-55. (IF: 6.6)
    • Vlkovicová J, Javorková V, Mézesová L, Pechánová O, Andriantsitohaina R, Vrbjar N. Dual effect of polyphenolic compounds on cardiac Na+/K+-ATPase during development and persistence of hypertension in rats. Can J Physiol Pharmacol. 2009;87(12):1046-54. (IF: 1.7)
    • Sarr M, Ngom S, Kane MO, Wele A, Diop D, Sarr B, Gueye L, Andriantsitohaina R, Diallo AS. In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta.Nutr Metab (Lond). 2009 ;2;6:45. (IF: 3.0)
    • Agouni A, Lagrue-Lak-Hal AH, Mostefai HA, Tesse A, Mulder P, Rouet P, Desmoulin F, Heymes C, Martínez MC, Andriantsitohaina R. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One. 2009;4(5):e5557. (IF : 4.3)
    • Diouf B, Collazos A, Labesse G, Macari F, Choquet A, Clair P, Gauthier-Rouvière C, Guérineau NC, Jay P, Hollande F, Joubert D. A 20-amino acid module of protein kinase C{epsilon} involved in translocation and selective targeting at cell-cell contacts. J Biol Chem. 2009;284:18808-18815. (IF: 5.3)
    • Colomer C, Desarménien MG, Guérineau NC. Revisiting the stimulus-secretion coupling in the adrenal medulla: role of gap junction-mediated intercellular communication. Mol Neurobiol. 2009;40:87-100. (IF: 4.7)
    • Kofoed, P.K., Milea, D., Larsen, M., 2009. Transient monocular blindness precipitated by sexual intercourse.Br J Ophthalmol 93, 1199, 1250. (IF:2.859)
    • Biousse V, Milea D et al. Management of Optic Neuritis and Impact of Clinical Trials: An International Survey. J Neurol Sci 2009 15;276(1-2):69-74. (IF: 2.3)
    • Ferre, M., Bonneau, D., Milea, D., Chevrollier, A., Verny, C., Dollfus, H., Ayuso, C., Defoort, S., Vignal, C., Zanlonghi, X., Charlin, J.F., Kaplan, J., Odent, S., Hamel, C.P., Procaccio, V., Reynier, P., Amati-Bonneau, P., 2009. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat 30, E692-705. (IF:7.033)
    • Gyllenborg, J., Milea, D., 2009. Ocular flutter as the first manifestation of Lyme disease. Neurology 72, 291.( IF : 7.043)
    • Mensah, A., Milea, D., Jensen, R., Fledelius, H., 2009. Persistent visual loss in malignant idiopathic intracranial hypertension. Acta Ophthalmol 87, 934-936. (IF: 1.9)
    • Belizna CCHamidou MA, Levesque H, Guillevin L, Shoenfeld Y. Infection and vasculitis. Rheumatology. 2009;48:475-82. (IF:4.136)
    • Belizna C, Pistorius MA, Planchon B. Lethal limb ischaemia in leukaemia. Case report and review of the literature. J Thromb Thrombolysis. 2009;28:354-7. (IF:6.291)
    • Bouhours-Nouet N, Gatelais F, Dufresne S, Rouleau S, Coutant R: [High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance]. Arch Pediatr 16:573-575, 2009 (IF:0.356)
    • Illouz F, Sandrine Laboureau-Soares S, Severine Dubois S, Vincent Rohmer V, Rodien P Tyrosine kinase inhibitors and modifications of thyroid function tests: A review. Eur J Endocrinol 2009; 160: 331-336.(IF:3.791)
    • Fontaine JF, Mirebeau-Prunier D, Raharijaona M, Franc B, Triau S, Rodien P, Goëau- Brissonniére O, Karayan-Tapon L, Mello M, Houlgatte R, Malthiery Y, Savagner F. Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers PLoS One 2009; 4(10):e7632. (IF: 4.351)
    • Cassereau J, Chevrollier A, Gueguen N, Malinge MC, Letournel F, Nicolas G, Richard L, Ferré M, Verny C, Dubas F, Procaccio V, Amati-Bonneau P, Bonneau D, Reynier P. Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie- Tooth disease (CMT2K). Neurogenetics 2009;10:145-50. (IF: 3.0)
    • NochezY,ArseneS,GueguenN,ChevrollierA,FerréM,GuilletV,DesquiretV,ToutainA, Bonneau D, Procaccio V, Amati-Bonneau P, Pisella PJ, Reynier P. Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect. Mol Vis 2009;15:598-608. (IF: 2.5)
    • Loiseau D, Morvan D, Chevrollier A, Demidem A, Douay O, Reynier P, Stepien G. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy. Mol Carcinog.2009;48:733-41. (IF: 3.6)
    • Ferré M, Bonneau D, Chevrollier A, Dollfus H, Milea D, Ayuso C, Defoort S, Vignal C,
    • Zanlonghi X, Charlin JF, Kaplan J, Odent S, Hamel C, Procaccio V, Reynier P, Amati- Bonneau P. Molecular screening of 980 cases of suspected of hereditary optic neuropathy with a report on 77 novel OPA1 mutations.Hum Mutat 2009;30:E692-705. (IF: 7.0)
    • Pierron D, Ferré M, Rocher C, Chevrollier A, Murail P, Thoraval D, Amati-Bonneau P, Reynier P, Letellier T. OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background. BMC Med Genet2009;10:70. (IF: 2.8)
    • Partsch CJ, Plauchu H, Rajab A, Rossi M,Sillence D, Steichen-Gersdorf E, Stewart H, Unger S, Zenker M, Munnich A, Cormier-Daire V. A large-scale mutation search reveals genetic heterogeneity in 3M syndrome. Eur J Hum Genet 2009;17(3):395-400. (IF: 3.9)
    • Naouri M, Boisseau C, Bonicel P, Daudon P, Bonneau D, Chassaing N, Martin L. Manifestations of pseudoxanthoma elasticum in childhood. British Journal of Dermatology, 2009, sous presse. Br J Dermatol2009;161:635-639. (IF: 3.4)
    • Casnovas C, Banchs I, Cassereau J, Gueguen N, Chevrollier A, Martínez-Matos JA, Bonneau D, Volpini V. Phenotypic Spectrum of MFN2 Mutations in the Spanish Population. J Med Genet 2009, in press. (IF: 5.7)
    • Casas F, Pessemesse L, Grandemange S, Seyer P, Baris O, Gueguen N, Ramonatxo C, Perrin F, Fouret G, Lepourry L, Cabello G, Wrutniak-Cabello C Overexpression of the mitochondrial T3 receptor induces skeletal muscle atrophy during aging. PLoS One 2009;4 e5631.
    • Flamment M, Gueguen N, Wetterwald C, Simard G, Malthièry Y, Ducluzeau PH. Effects of the cannabinoid CB1 antagonist, rimonabant, on hepatic mitochondrial function in rats fed a high fat diet. Am J Physiol Endocrinol Metab 2009 [Epub J Physiol Endocrinol Metab]. (IF: 3.9)
    • Ritz P, Becouarn G, Douay OSallé A, Topart P, Rohmer V. Gastric Bypass is not Associated with Protein Malnutrition in Morbidly Obese Patients. Obes Surg 2009;19:840-4. (IF: 2.9)
    • Dhaenens CM, Burnouf S, Simonin C, Vanbrussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, JP Azulay, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D, on behalf the Huntington French Speaking Network. A genetic variation in the ADORA2A gene modifies age at onset in Huntington’s disease. Neurobiol Dis 2009;35:474- 6.(IF: 4.9)
    • Devillé J., Rey J. and Chabbert M. An indel in transmembrane helix 2 helps to trace the molecular evolution of class A G-protein coupled receptors. J. Mol. Evol., 2009,  68: 475-89 (IF: 2.8)
    • Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Lévi AC, Hantraye P, Remy P. In vivo evidence for the selective subcortical degeneration in Huntington's disease. Neuroimage 2009;46:958-66. (IF: 5.7)

    2008


    • • Belin de Chantemele EJ, Retailleau K, Pinaud F, Vessieres E, Bocquet A, Guihot AL, Lemaire B, Domenga V, Baufreton C, Loufrani L, Joutel A, Henrion D. Notch3 Is a Major Regulator of Vascular Tone in Cerebral and Tail Resistance Arteries. Arterioscler Thromb Vasc Biol. 2008 ;28:2216-24. (IF: 6.9)
    • • Dumont O, Pinaud F, Guihot AL, Baufreton C, Loufrani L, Henrion D. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine. Cardiovasc Res. 2008;77:600-608. (IF: 5.9)
    • • Guilluy C, Rolli-Derkinderen M, Loufrani L, Bourge A, Henrion D, Sabourin L, Loirand G, Pacaud P. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation. Circ Res. 2008;102:1265-1274. (IF: 10.0)
    • • Holopherne D, Mallem MY, Le Strat E, de Chantemele EJ, Gogny M, Henrion D, Noireaud J, Desfontis JC. CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats. Eur J Pharmacol. 2008;591:196-202. (IF: 2.8)
    • • Loufrani L, Retailleau K, Bocquet A, Dumont O, Danker K, Louis H, Lacolley P, Henrion D. Key role of alpha(1)beta(1)-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries. Am J Physiol. 2008;294:H1906-1913. (IF: 3.6)
    • • Mostefai HA, Agouni A, Carusio N, Mastronardi ML, Heymes C, Henrion D, Andriantsitohaina R, Martinez MC. Phosphatidylinositol 3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells. J Immunol. 2008;180:5028-5035. (IF: 6.0)
    • • Novoselova AM, Custaud MA, Tsvirkun DV, Larina IM, Kulchitsky VA. Metabolism in rats during antiorthostatic hypokinesia. Bull Exp Biol Med. 2008;146:38-40.(IF:0.258)
    • • Rousseau P, Tartas M, Fromy B, Godon A, Custaud MA, Saumet JL, Abraham P. Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans.Am J Physiol. 2008;294:R1420-6. (IF: 3.6)
    • • Ducluzeau PH, Berlie P, Leftheriotis G, de Bray JM, Fortrat JO. A truncated ultrasound screening procedure for atheroma of the cervical arteries in asymptomatic diabetic patients: Evidence from a retrospective study. Diabetes Metab. 2008;34:370-4. (IF: 2.1)
    • • Comprehensive analysis of the helix-X-helix motif in soluble proteins. Devillé J, Rey J Chabbert M. Proteins, 2008;72: 115-135. (IF: 3.4)
    • • Rousseau P, Tartas M, Fromy B, Godon A, Custaud MA, Saumet JL, Abraham P. Platelet inhibition by low dose Aspirin but not by Clopidogrel reduces the axon-reflex current-induced vasodilation in humans.Am J Physiol; 2008 294(5):R1420-6. (IF 3.272)
    • • Le Faucheur A, Abraham P, Jaquinandi V, Bouye P, Saumet JL, Noury-Desvaux B. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system.Circulation 2008;117(7):897-904. (IF 14.595)
    • • Jaquinandi V, Picquet J, Saumet JL, Benharash P, Leftheriotis G, Abraham P. Functional assessment at the buttock level of the effect of aortobifemoral bypass surgery. Ann Surg. 2008 May;247(5):869-76 (IF : 8.0)
    • • Gagnadoux F, Hureaux J, Vecellio L, Urban T, Le Pape A, Valo I, Montharu J, Leblond V, Boisdron-Celle M, Lerondel S, Majoral C, Diot P, Racineux JL, Lemarie E. Aerosolized chemotherapy. J Aerosol Med Pulm Drug Deliv 2008;21(1):61-70. (IF: 2.108)
    • • Gindre L, Gagnadoux F, Meslier N, Gustin JM, Racineux JL. Mandibular advancement for obstructive sleep apnea: dose effect on apnea, long-term use and tolerance. Respiration 2008;76(4):386-92. (IF: 1.985)
    • • Martin L, Maitre F, Bonicel P, Daudon P, Verny C, Bonneau D, Le Saux O, Chassaing N. Heterozygosity for a single mutation in the ABCC6 gene may closely mimic PXE: consequences of this phenotype overlap for the definition of PXE. Arch Dermatol 2008;144(3):301-6. (IF: 3.4)
    • • Bannwarth S., Procaccio V., Rouzier C., Fragaki K., Poole J., Vialettes B., Chabrol B., Desnuelle C., Pouget J., Azulay J.P., Attarian S., Pellissier J.F., Gargus J., Abdenur J., Mozaffar T., Calvas P., Labauge P., Raccah D., Pages M., Wallace D.C., Lambert J.C., Paquis-Flucklinger V. Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using Surveyor strategy. Mitochondrion(2008) 8: 136-145. (IF: 4.3)
    • • Cornille K, Milea D, Amati-Bonneau P, Procaccio V., Zazoun L, Guillet V, El Achouri G, Gueguen N, Loiseau D, Muller A, Ferré M, Chevrollier A, Wallace DC, Bonneau D, Hamel C, Reynier P, Lenaers G. Acute reversible optic neuropathy associated with alternative exon 5b mutation in OPA1 and hyperfilamentous mitochondrial network. Annals of Neurology (2008) 63: 667-671. (IF: 9.9)
    • • Chevrollier A, Guillet V, Loiseau D, Guegen N, Pou de Crescenzo MA, Verny C, Ferre M, Dollfus H, Odent S, Milea D, Goizet C, Malthierry Y, Amati-Bonneau P, Procaccio V, Bonneau D, Reynier P. Hereditary optic neuropathies share a common mitochondrial coupling defect. Annals of Neurology (2008) 63(6):794-8. (IF: 9.9)
    • • Razmara A, Sunday L, Stirone C., Krause D.N., Duckles S.P, Procaccio V. Mitochondrial effects are mediated by ER alpha in brain endothelial cells. Journal of Pharmacology and Experimental Therapeutics (2008) 325: 782-790. (IF: 4.3)
    • • Khidr L, Wu G, Davila A, Procaccio V., Wallace D, Lee WH. Role of SUV3 helicase in maintaining mitochondrial homeostasis in human cells. (2008) Journal of Biological Chemistry (2008) 283: 27064-27073.(IF: 5.5)
    • • Verny C, Amati-Bonneau P, Letournel F, Dib Person B, N, Malinge MC, Slama A, Le Maréchal C, Ferec C, Procaccio V, Reynier P, Bonneau D. Mitochondrial DNA A3243G mutation involved in familial diabetes, chronic intestinal pseudo-obstruction and recurrent pancreatitis. Diabetes and Metabolism (2008) 34, 620-626. (IF: 2.1)
    • • Mostefai HA, Meziani F, Mastronardi ML, Agouni A, Heymes C, Sargentini C, Asfar P, Martinez MC, Andriantsitohaina R Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med. 2008;178:1148-55. (IF:9.8)
    • • Sall Diallo A, Sarr M, Mostefai HA, Carusio N, Pricci M, Andriantsitohaina R. Cognac polyphenolic compounds increase bradykinin-induced nitric oxide production in endothelial cells. Physiol Res. 2008;5:885-92. (IF: 1.6)
    • • Meziani F, Tesse A, Welsch S, Kremer H, Barthelmebs M, Andriantsitohaina R, Schneider F, Gairard A. Expression and biological activity of parathyroid hormone-related peptide in pregnant rat uterine artery: any role for 8-iso-prostaglandin F2alpha? Endocrinology. 2008;14:626-33. (IF: 4.9)
    • • Tesse A, Al-Massarani G, Wangensteen R, Reitenbach S, Martínez MC, Andriantsitohaina R. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins. J Pharmacol Exp Ther. 2008;324(2):539-47. (IF: 4.3)
    • • Carusio N, Wangensteen R, Filippelli A, Andriantsitohaina R. Oral administration of polyphenolic compounds from cognac decreases ADP-induced platelet aggregation and reduces chronotropic effect of isoprenaline in rats.Physiol Res. 2008;57(4):517-24. (IF: 1.6)
    • • Mingorance C, Andriantsitohaina R, Alvarez de Sotomayor M. Cedrelopsis grevei improves endothelial vasodilatation in aged rats through an increase of NO participation. J Ethnopharmacol. 2008;117(1):76-83. (IF: 2.3)
    • • Ritz MF, Ratajczak P, Curin Y, Cam E, Mendelowitsch A, Pinet F, Andriantsitohaina R. Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J Nutr.2008;138(3):519-25. (IF: 3.5)
    • • Benamar A, Rolletschek H, Borisjuk L, Avelange-Macherel MH, Curien G, Mostefai HA, Andriantsitohaina R, Macherel D. Nitrite-nitric oxide control of mitochondrial respiration at the frontier of anoxia.Biochim Biophys Acta. 2008 ;1777(10):1268-75. (IF: 2.6)
    • • Ritz MF, Curin Y, Mendelowitsch A, Andriantsitohaina R. Acute treatment with red wine polyphenols protects from ischemia-induced excitotoxicity, energy failure and oxidative stress in rats. Brain Res.2008;1239:226-34.(IF: 2.5)
    • • Mostefai HA, Meziani F, Mastronardi ML, Agouni A, Heymes C, Sargentini C, Asfar P, Martinez MC, Andriantsitohaina R. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med. 2008;178:1148-55. (IF: 9.8)
    • • Nacira S, Ferhat M, Olivier D, Valérie C, Solène C, Chantal M, Sebastien G, Pierre A, Andriantsitohaina R, Veronique R, Michel S, Thomas L, Patrick L, Bruno L. Activated protein C improves LPS-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress. Crit Care Med. 2008 (IF: 6.8)
    • • Birenbaum A, Tesse A, Loyer X, Michelet P, Andriantsitohaina R, Heymes C, Riou B, Amour J. Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology. 2008;109(6):1045-53. (IF: 5.1)
    • • Mostefai HA, Andriantsitohaina R, Martínez MC. Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res 2008;57(3):311-20. Review. (IF: 1.6)
    • • Meziani F, Tesse A, Andriantsitohaina R. Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol Rep. 2008;6:75-84. Review.(IF: 1.6)
    • • Grumolato L, Ghzili H, Montero-Hadjadje M, Gasman S, Lesage J, Tanguy Y, Galas L, Ait-Ali D, Leprince J, Guérineau NC, Elkahloun AG, Fournier A, Vieau D, Vaudry H, Anouar Y. Selenoprotein T is a PACAP-regulated gene involved in intracellular Ca2+ mobilization and neuroendocrine secretion. FASEB J. 2008;22:1756-1768. (IF: 6.4)
    • • Colomer C, Olivos Ore LA, Coutry N, Mathieu MN, Arthaud S, Fontanaud P, Iankova I, Macari F, Thouënnon E, Yon L, Anouar Y, Guérineau NC. Functional remodeling of gap junction-mediated electrical communication between adrenal chromaffin cells in stressed rats. J Neurosci. 2008;28:6616-6626. (IF: 7.2)
    • • Colomer C, Lafont C, Guérineau NC. Stress-induced intercellular communication remodeling in the rat adrenal medulla. Ann N Y Acad Sci. 2008;1148:106-111. (IF: 2.7)
    • • Iankova I, Chavey C, Clapé C, Colomer C, Guérineau NC, Grillet N, Brunet JF, Annicotte JS, Fajas L. Regulator of G protein signaling-4 controls fatty acid and glucose homeostasis.Endocrinology. 2008;149:5706-5712. (IF: 4.7)
    • • Chevrollier, A., Guillet, V., Loiseau, D., Gueguen, N., de Crescenzo, M.A., Verny, C., Ferre, M., Dollfus, H., Odent, S., Milea, D., Goizet, C., Amati-Bonneau, P., Procaccio, V., Bonneau, D., Reynier, P., 2008.Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol 63, 794-798. (IF:9.9)
    • • Cornille, K., Milea, D., Amati-Bonneau, P., Procaccio, V., Zazoun, L., Guillet, V., El Achouri, G., Delettre, C., Gueguen, N., Loiseau, D., Muller, A., Ferre, M., Chevrollier, A., Wallace, D.C., Bonneau, D., Hamel, C., Reynier, P., Lenaers, G., 2008. Reversible optic neuropathy with OPA1 exon 5b mutation. Ann Neurol 63, 667-671. (IF:9.9)
    • • Guillery, O., Malka, F., Frachon, P., Milea, D., Rojo, M., Lombes, A., 2008. Modulation of mitochondrial morphology by bioenergetics defects in primary human fibroblasts. Neuromuscul Disord 18, 319-330.(IF:2.932)
    • • Haargaard, B., Lund-Andersen, H., Milea, D., 2008. Central nervous system involvement after herpes zoster ophthalmicus. Acta Ophthalmol 86, 806-809. (IF:1.9)
    • • Tilikete, C., Milea, D., Pierrot-Deseilligny, C., 2008. Upbeat nystagmus from a demyelinating lesion in the caudal pons. J Neuroophthalmol 28, 202-206. (IF:0.11)
    • • Belizna C, Lartigue A, Favre J, Gilbert D, Tron F, Lévesque H, Thuillez C, Richard V. Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome? Lupus. 2008; 17:185-94. (IF: 2.244)
    • • Belizna CC, Richard V, Primard E, Kerleau JM, Cailleux N, Louvel JP, Marie I, Hamidou M, Thuillez C, Lévesque H. Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding.Semin Arthritis Rheum. 2008 ;37:373-80. (IF:4.379)
    • • Belizna CC, Kerleau JM, Heron F, Cailleux N, Lévesque H. Vasculitis and myelodysplasia. Isr Med Assoc J. 2008;10:156-7. (IF:0.626)
    • • Belizna CC, Tron F, Joly P, Godin M, Hamidou M, Lévesque H. Outcome of essential cryofibrinogenaemia in a series of 61 patients. Rheumatology. 2008;47:205-7. (IF:4.136)
    • • Bouhours-Nouet N, Dufresne S, de Casson FB, Mathieu E, Douay O, Gatelais F, Rouleau S, Coutant R: High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects? Diabetes Care 31:1031-1036, 2008 ( IF:7.349)
    • • Bonnemains L, Rouleau S, Sing G, Bouderlique C, Coutant R: Severe neonatal hypercalcemia caused by subcutaneous fat necrosis without any apparent cutaneous lesion. Eur J Pediatr 167:1459-1461, 2008(IF:1.461)
    • • Fontaine JF, Mirebeau-Prunier D, Franc B, Triau S, Rodien P, Houlgatte R, Malthièry Y, Savagner F. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy.Oncogene. 2008; 27: 2228-36. (IF:7.216)
    • • Hamon B, Hamon P, Bovier-Lapierre M, Pugeat M, Savagner F, Rodien P, Orgiazzi J. A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up.Thyroid. 2008;18: 35-44. (IF:3.00)
    • • Dubois S, Abraham P, Rohmer V, Rodien P, Audran M, Dumas JF, Ritz P. Thyroxine therapy in euthyroid patients does not affect body composition or muscular function. Thyroid. 2008;18: 13-9. . (IF:3.00)
    • • Royer J, Lefevre-Minisini A, Caltabiano G, Lacombe T, Malthiery Y, Savagner F, Pardo L, Rodien P.The cloned equine thyrotropin receptor is hypersensitive to human chorionic gonadotropin; identification of three residues in the extracellular domain involved in ligand specificity. Endocrinology. 2008; 149: 5088-5096 (IF:4.945)
    • • Rodien P. Rituximab in Graves' disease. Eur J Endocrinol. 2008; 159: 515-516 (IF:3.791
    • • Borson-Chasot F, Bardet S, Bournaud C, Conte-Devolx B, Corone C, D'Herbomez M, Henry JF, Leenhardt L, Peix JL, Schlumberger M, Wemeau JL; Expert Group for French Recommendations for the Management of Differentiated Thyroid Carcinomas of Vesicular Origin, Baudin E, Berger N, Bernard MH, Calzada-Nocaudie M, Caron P, Catargi B, Chabrier G, Charrie A, Franc B, Hartl D, Helal B, Kerlan V, Kraimps JL, Leboulleux S, Le Clech G, Menegaux F, Orgiazzi J, Perié S, Raingeard I, Rodien P, Rohmer V, Sadoul JL, Schwartz C, Tenenbaum F, Toubert ME, Tramalloni J, Travagli JP, Vaudrey C. Guidelines for the management of differentiated thyroid carcinomas of vesicular origin. Ann Endocrinol (Paris). 2008;69:472-86. (IF:0.446)
    • • Fassot C., Briet M., Rostagno P., Barbry P., Perret C., Laude D., Boutouyrie P., Bozec E., Bruneval P., Latremouille C., Laurent S. Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary disease. Journal of Hypertension, 2008 ; 26:747-757. (IF:5.132)
    • • Bodineau L., Frugière A., Marc Y., Inguimbert N., Fassot C., Balavoine F., Roques B., Llorens-Cortes C. Orally active aminopeptidase A inhibitors reduce blood pressure : a new strategy for treating hypertension.Hypertension, 2008 ; 51:1-8. (IF:7.368)
    • • De Mota N., Iturrioz X., Claperon C., Bodineau L., Fassot C., Roques B., Palkovits M. And Llorens-Cortes C. Human brain aminopeptidase A : biochemical properties and distribution in brain nuclei. Journal of Neurochemistry, 2008; 106: 416-28. (IF:4.5)
    • • Nehiri T., Duong Van Huyen J.P., Viltard M., Fassot C., Heudes D., Freund N., G. Deschênes , Houillier P., Bruneval P. And Lelièvre-Pégorier M. Exposure to maternal diabetes induces salt-sensitive hypertension and impairs renal function in rat offspring. Diabetes, 2008; 57: 2167-75. (IF:8.398)
    • • Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM,Griffiths PG, Ahlqvist K, Suomalainen S, Reynier P, McFarland R, Turnbull DM, Chinnery PF, Taylor RW. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain. 2008;131:329-37. (IF: 9.6)
    • • Amati-Bonneau P, Valentino ML, Reynier P, Gallardo E, Bornstein B, Boissière A, Campos Y, Rivera H, González de la Aleja J, Carroccia R, Iommarini L, Labauge P, Figarella-Branger D, Marcorelles P, Furby A, Beauvais K, Letournel F, Liguori R, La Morgia C, Montagna P, Liguori M, Zanna C, Rugolo M, Cossarizza A, Wissinger B, Verny C, Schwarzenbacher R, Ángel Martín M, Arenas J, Ayuso C, GaresseR, Lenaers G, Bonneau D, Carelli V. OPA1 mutations induce mitochondrial DNA instability and optic atrophy “plus” phenotypes. Brain 2008;131:338-51. (IF: 9.6)
    • • Verny C, Loiseau D, Scherer C, Lejeune P, Chevrollier A, Gueguen N, Guillet V, Dubas F, Reynier P, Amati-Bonneau P, Bonneau D. Multiple-sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology 2008;70:1152-3. (IF: 7.0)
    • • Cornille K, Milea D, Amati-Bonneau P, Procaccio V, Zazoun L, Guillet V, ElAchouri G, Delettre C, Gueguen N, Loiseau D, Muller A, Ferré M, Chevrollier A, Wallace DC, Bonneau D, Hamel C, Reynier P, Lenaers G. Reversible optic neuropathy with OPA1 exon 5b mutation. Ann Neurol 2008, 63:667-71. (IF: 9.9)
    • • Chevrollier A, Guillet V, Loiseau D, Gueguen N, Pou de Crescenzo MA, Verny C, Ferre M, Dollfus H, Odent S, Milea D, Goizet C, Amati-Bonneau P, Procaccio V, Bonneau D, Reynier P. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol 2008;63:794-8. (IF: 9.9)
    • • Pierron D, Rocher C, Amati-Bonneau P, Reynier P, Martin-Negrier ML, Allouche S, Batandier C, Mousson de Camaret B, Godinot C, Rotig A, Feldmann D, Bellanne-Chantelot, Arveiller, Pennarun E, Rossignol R, Crouzet M, Murail P, Thoraval D, Letellier T. Impact of mitochondrial genetic background paradox: Impact of the J haplogroups on A3243G mutation. BMC Med Genet 2008;9:41. (IF: 2.8)
    • • Verny C, Amati-Bonneau P, Letournel F, Dib N, Person B, Malinge MC, Le Marechal C, Ferec C, Reynier P, Bonneau D. Familial chronic pseudo-obstruction and recurrent pancreatitis in patients harbouring the mitochondrial DNA A3243G mutation. Diabetes Metab 2008;34:620-6. (IF: 2.1)
    • • Perrin A, Douet-Guilbert N, Le Bris MJ, May-Panloup P, Guichet A, Amice V, Amice J, De Braekeleer M, Morel F. Increased aneuploidy rates in spermatozoa of a male carrier of a trisomy 18 mosaicism. Int J Androl2008;32:231-234.(IF:4.021)
    • • Pénisson-Besnier I, Lebouvier T, Moizard MP, Ferré M, Barth M, Marc G, Ravnaud M, Bonneau D. Carotid artery dissection in an adult with the Simpson-Golabi-Behmel syndrome. Am J Med Genet A 2008;146:464-7. (IF : 2.6)
    • • Schneider A, Benzacken B, Guichet A, Verloes A, Bonneau D, Collot N, Dastot-Le-Moal F, Landais E, Goossens M, Gaillard D, Doco-Fenzy M. Molecular cytogenetic characterization of terminal 14q32 deletions in two children with an abnormal phenotype and hypoplasia of corpus callosum. Eur J Hum Genet 2008;16:680-687. (IF: 3.9)
    • • Martin L, Maître F, Bonicel P, Daudon P, Verny C, Bonneau D, Le Saux O, Chassaing N. Heterozygosity for a single mutation in the ABCC6 gene may closely mimic pseudoxanthoma elasticum (PXE). Consequences of this phenotype overlap for the definition of PXE. Arch Dermatol 2008;144:301-306. (IF: 3.4)Pézard P, Bonnemains L, Boussion F, Sentilhes L, Allory P, Lépinard C, Guichet A, Triau S, Biquard F, Leblanc M, Bonneau D, Descamps P. Influence of ultrasonographers training on prenatal diagnosis of congenital heart diseases: a 12-year population-based study. Prenat Diagn 2008;28:1016-22. (IF: 1.5)
    • • Desquiret V, Gueguen N, Malthièry Y, Ritz P, Simard G. Mitochondrial effects of dexamethasone imply both membrane and cytosolic-initiated pathways in HepG2 cells. Int J Biochem Cell Biol2008;40:1629-41 (IF : 4.2)
    • • Casas F, Pessemesse L, Grandemange S, Seyer P, Gueguen N, Baris O, Lepourry L, Cabello G, Wrutniak-Cabello C. Overexpression of the mitochondrial T3 receptor p43 induces a shift in skeletal muscle fiber types. PLoS ONE2008;3 e2501.
    • • Ryan M, Livingstone MB, Ducluzeau PH, Sallé A, Genaitay M, Ritz P. Is a failure to recognize an increase in food intake a key to understanding insulin-induced weight gain? Diabetes Care 2008;31:448-450.(IF: 7.3)
    • • Tichet J, Vol S, Goxe D, Salle A, Berrut G, Ritz P. Prevalence of sarcopenia in the French senior population. J Nutr Health Aging 2008;12:202-206. (IF: 2.3)
    • • Gaillard C, Alix E, Salle A, Berrut G, Ritz P. A practical approach to estimate resting energy expenditure in frail elderly people. J Nutr Health Aging 2008;12:277-280. (IF: 2.3)
    • • Johnson G, Sallé A, Lorimier G, Laccourreye L, Enon B, Blin V, Jousset Y, Arnaud JP, Malthièry Y, Simard G, Ritz P. Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation.Nutrition 2008;24:443-450. (IF: 2.3)
    • • Cassereau J, Lavigne C, Letournel F, Ghali A, Verny C, Dubas F, Devière F, Nicolas G. Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin. J Peripher Nerv Syst 2008;13:251-4. (IF: 2.8)
    • • Teichmann M, Gaura V, Démonet JF, Supiot F, Delliaux M, Verny C, Renou P, Remy P, Bachoud-Lévi AC. Language processing within the striatum: evidence from a PET correlation study in Huntington's disease. Brain2008;131:1046-56. (IF: 9.6)
    • • Verny C, Marc G, Pasco-Papon A, Dubas F. Middle cerebral artery dissection gives rise to giant serpentine aneurysm. Cerebrovasc Dis 2008;25:283-285. (IF: 3.0)

    2007

    • • Agouni A, Mostefai HA, Porro C, Carusio N, Favre J, Richard V, Henrion D, Martinez MC, Andriantsitohaina R. Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release. FASEB J. 2007;21:2735-2741. (IF:7.1)
    • • Baron-Menguy C, Bocquet A, Guihot AL, Chappard D, Amiot MJ, Andriantsitohaina R, Loufrani L, Henrion D. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 2007;21:3511-3521. (IF:7.1)
    • • Bouvet C, Belin de Chantemele E, Guihot AL, Vessieres E, Bocquet A, Dumont O, Jardel A, Loufrani L, Moreau P, Henrion D. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension. 2007;50:248-254. (IF:7.4)
    • • Dubroca C, Loyer X, Retailleau K, Loirand G, Pacaud P, Feron O, Balligand JL, Levy BI, Heymes C, Henrion D. RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc Res. 2007;73:190-197. (IF:5.9)
    • • Dumont O, Loufrani L, Henrion D. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler Thromb Vasc Biol. 2007;27:317-324.(IF:6.9)
    • • Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P, Guy N, Heurteaux C, Lazdunski M, Saumet JL.Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO Rep. 2007;8:354-359. (IF:7.1)
    • • Pinaud F, Bocquet A, Dumont O, Retailleau K, Baufreton C, Andriantsitohaina R, Loufrani L, Henrion D. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats.Hypertension. 2007;50:96-102. (IF:7.4)
    • • de Souza Neto EP, Abry P, Loiseau P, Cejka JC, Custaud MA, Frutoso J, Gharib C, Flandrin P. Empirical mode decomposition to assess cardiovascular autonomic control in rats. Fundam Clin Pharmacol. 2007;21:481-96. (IF:2.1)
    • • Demiot C, Dignat-George F, Fortrat JO, Sabatier F, Gharib C, Larina I, Gauquelin-Koch G, Hughson R, Custaud MA. WISE 2005: chronic bed rest impairs microcirculatory endothelium in women. Am J Physiol.2007;293:H3159-64. (IF:3.6)
    • • Fortrat JO, Schang D, Bellard E, Victor J, Leftheriotis G. Cardiovascular variables do not predict head-up tilt test outcome better than body composition. Clin Auton Res. 2007;17:206-210. (IF:1.5)
    • • Bellard E, Fortrat JO, Custaud MA, Victor J, Greenleaf J, Lefthériotis G. Increased hydration alone does not improve orthostatic tolerance in patients with neurocardiogenic syncope. Clin Auton Res.2007;17:99-105. (IF:1.5)
    • • Alecu C, Fortrat JO, Ducrocq X, Vespignani H, de Bray JM. Duplex scanning diagnosis of internal carotid artery dissections. A case control study. Cerebrovasc Dis. 2007;23:441-447. (IF:3.0)
    • • Schang D, Feuilloy M, Plantier G, Fortrat JO, Nicolas P. Early prediction of unexplained syncope by support vector machines. Physiol Meas. 2007;28:185-97. (IF:1.7)
    • • Le Faucheur A, Abraham P, Jaquinandi V, Bouye P, Saumet JL, Noury-Desvaux B. Study of human outdoor walking with a low-cost GPS and simple spreadsheet analysis. Med Sci Sports Exerc2007;39(9):1570-8.(IF:3.399)
    • • Jaquinandi V, Picquet J, Bouye P, Saumet JL, Leftheriotis G, Abraham P. High prevalence of proximal claudication among patients with patent aortobifemoral bypasses. J Vasc Surg 2007;45(2):312-8.(IF:3.770)
    • • Jaquinandi V, Abraham P, Picquet J, Paisant-Thouveny F, Leftheriotis G, Saumet JL. Estimation of the functional role of arterial pathways to the buttock circulation during treadmill walking in patients with claudication. J Appl Physiol 2007;102(3):1105-12. (IF: 3.658)
    • • Edgell H, Zuj KA, Greaves DK, Shoemaker JK, Custaud MA, Kerbeci P, Arbeille P, Hughson RL. WISE-2005: adrenergic responses of women following 56-days, 6 degrees head-down bed rest with or without exercise countermeasures. Am J Physiol Regul Integr Comp Physiol 2007;293(6):R2343-52. (IF:3.272)
    • • Fromy B, Sigaudo-Roussel D, Baron C, Roquelaure Y, Leftheriotis G, Saumet JL. Neuroendocrine pathway involvement in the loss of the cutaneous pressure-induced vasodilatation during acute pain in rats. J Physiol2007;579(Pt 1):247-54. (IF:4.649)
    • • JL, Urban T. Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer 2007;58(1):139-43.(IF:2.970)
    • • Chassaing N, Martin L, Bourthoumieu S, Calvas P, Hovnanian A. Contribution of ABCC6 genomic rearrangements to the diagnosis of pseudoxanthoma elasticum in French patients. Hum Mutat2007;28(10):1046. (IF:7.0)
    • • Martin L, Chassaing N, Delaite D, Esteve E, Maitre F, Le Bert M. Histological skin changes in heterozygote carriers of mutations in ABCC6, the gene causing pseudoxanthoma elasticum. J Eur Acad Dermatol Venereol2007;21(3):368-73. (IF: 2.3)
    • • Vanakker OM, Martin L, Gheduzzi D, Leroy BP, Loeys BL, Guerci VI, Matthys D, Terry SF, Coucke PJ, Pasquali-Ronchetti I, De Paepe A. Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 2007;127(3):581-7. (IF: 5.3)
    • • Sarzi E, Brown M, Lebon S, Chretien D, Munnich A, Rotig A, Procaccio V. A novel recurrent mtDNA mutation in ND3 gene causing Leigh syndrome and dystonia. American Journal of Medical Genetics(2007) 143: 33-41. (IF :3.9)
    • • Ruiz-Pesini E, Lott MT, Procaccio V, Poole J, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC.An Enhanced MITOMAP with a Global mtDNA Mutational Phylogeny. Nucleic Acid Research (2007) 35: D823-D828. (IF:6.9)
    • • Cano A, Rouzier C, Monnot S, Chabrol B, Conrath  J, Lecomte P, Delobel B, Boileau P, Valero R, Procaccio V, Paquis-Flucklinger V, French Group of Wolfram syndrome and Vialettes B. Identification of novel mutations in WFS1 and genotype-phenotype correlation in Wolfram syndrome. American Journal of Medical Genetics(2007) 143A : 1605-1612. (IF :3.9)
    • • Leveque M, Marlin S, Jonard L, Procaccio V, Reynier P, Amati-Bonneau P, Baulande S, Lacombe D, Duriez F, Francannet C, Mom T, Journel H, Catros H, Drouin-Garraud V, Obstoy MF, Dollfus, Eliot MM, Faivre L, Duvillard C, Couderc R, Garabedian EN, Petit C, Feldmann D, Denoyelle F. Mitochondrial Mutations in Maternally-Inherited Non-Syndromic Hearing Impairment: Prevalence of Known Mutations and Whole Mitochondrial Genome Screening using a Microarray Resequencing Mitochondrial DNA Chip.European Journal of Human Genetics (2007) 15, 1145–1155. (IF :3.9)
    • • Razmara A, Sunday L, Stirone C., Krause D.N., Duckles S.P, Procaccio V. Estrogen Suppresses Brain Mitochondrial Oxidative Stress in Female and Male Rats. Brain Research (2007) 1176:71-81. (IF :2.5)
    • • Alvarez de Sotomayor M, Mingorance C, Andriantsitohaina R. Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries. Atherosclerosis. 2007;193:112-20. (IF: 4.6)
    • • Chaabi M, Freund-Michel V, Frossard N, Randriantsoa A, Andriantsitohaina R, Lobstein A. Anti-proliferative effect of Euphorbia stenoclada in human airway smooth muscle cells in culture. J Ethnopharmacol. 2007;109(1):134-9. (IF: 3.2)
    • • Tesse A, Meziani F, David E, Carusio N, Kremer H, Schneider F, Andriantsitohaina R. Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO. Am J Physiol. 2007;293:H520-5. (IF: 3.6)
    • • Ralay Ranaivo H, Carusio N, Wangensteen R, Ohlmann P, Loichot C, Tesse A, Chalupsky K, Lobysheva I, Haiech J, Watterson DM, Andriantsitohaina R. Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice. Am J Pathol. 2007;170:439-46. (IF: 5.7)
    • • Meziani F, Kremer H, Tesse A, Baron-Menguy C, Mathien C, Mostefai HA, Carusio N, Schneider F, Asfar P, Andriantsitohaina R. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol. 2007;171:1753-61. (IF: 5.7)
    • • Diebolt M, Laflamme K, Labbé R, Auger FA, Germain L, Andriantsitohaina R. Polyphenols modulate calcium-independent mechanisms in human arterial tissue-engineered vascular media. J Vasc Surg. 2007;46(4):764-72. (IF: 3.77)
    • • Amour J, Loyer X, Le Guen M, Mabrouk N, David JS, Camors E, Carusio N, Vivien B, Andriantsitohaina R,Heymes C, Riou B. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology. 2007;107(3):452-60. (IF: 5.1)
    • • Ster J, De Bock F, Guérineau NC, Janossy A, Barrère-Lemaire S, Bos JL, Bockaert J, Fagni L. Exchange protein activated by cAMP (Epac) mediates cAMP activation of p38 MAPK and modulation of Ca2+-dependent K+ channels in cerebellar neurons. Proc Natl Acad Sci U S A. 2007;104:2519-2524. (IF: 9.4)
    • • Gallien, S., Milea, D., Thiebaut, M.M., Bricaire, F., Le Hoang, P., 2007. Brain and optic nerve ischemia in malaria with immune disorders. J Infect 54, e1-3. (IF:3.089)
    • • Khonsari, R.H., Lobel, E., Milea, D., Lehericy, S., Pierrot-Deseilligny, C., Berthoz, A., 2007. Lateralized parietal activity during decision and preparation of saccades. Neuroreport 18, 1797-1800.Milea, D., 2007. [Recognizing the pitfalls. Non-glaucomatous optic disc cupping]. J Fr Ophtalmol 30, 3S31-34 (IF:0.45)
    • • Milea, D., Lobel, E., Lehericy, S., Leboucher, P., Pochon, J.B., Pierrot-Deseilligny, C., Berthoz, A., 2007. Prefrontal cortex is involved in internal decision of forthcoming saccades. Neuroreport 18, 1221-1224. (IF:1.094)
    • • Soliman, W., Larsen, M., Sander, B., Wegener, M., Milea, D., 2007. Optical coherence tomography of astrocytic hamartomas in tuberous sclerosis. Acta Ophthalmol Scand 85, 454-455. (IF:1.9)
    • • Belizna C, Kerleau JM, Heron F, Lévesque H. Tonsillar and lymph node tuberculosis revealing asymptomatic pulmonary tuberculosis. QJM. 2007 100:800-1 (IF:2.483)
    • • Bouhours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S, Coutant R: The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. J Clin Endocrinol Metab 92:629-635, 2007 (IF:6.325)
    • • Coutant R, Mallet D, Lahlou N, Bouhours-Nouet N, Guichet A, Coupris L, Croue A, Morel Y: Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome. J Clin Endocrinol Metab 92:2868-2873, 2007
    • • Illouz F, Rodien P, Saint-Andre JP, Triau S, Laboureau-Soares S, Dubois S, Vielle B, Hamy A, Rohmer V. Usefulness of repeated fine-needle cytology in the follow-up of non-operated thyroid nodules. Eur J Endocrinol. 2007 Mar;156(3):303-8. (IF:3.791)
    • • Dubois-Ginouves S, Guyétant S, Menei P, Rodien P, Vielle B, Rohmer V. Relevance of KI-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery. Eur J Endocrinol2007; 157: 1-8. (IF:3.791)
    • • Dubois S, Morel O, Rodien P, Illouz F, Girault S, Cahouet A, Lacoeuille F, Brousseau M, Picquet J, Rohmer V. A Pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-Fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome. J Clin Endocrinol Metab. 2007; 92: 4512-3. (IF:6.325)
    • • Laurent S., Fassot C., Lacolley P., Boutouyrie P. Molecular determinants of arterial stiffness. Artery Research, 2007 ; 1:26-31.
    • • Iturrioz X, El Messari S, De Mota N, Fassot , Alvear-Perez R., Maigret B., Llorens-Cortes C. [Functional dissociation between apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure]. Archives des Maladies du Coeur et des Vaisseaux, 2007;100:704-8. (IF:0.265)
    • • Olichon A, Landes T, Arnauné-Pelloquin L, Emorine LJ, Mils V, Guichet A, Delettre C, Hamel C, Amati-Bonneau P, Bonneau D, Reynier P, Lenaers G, Belenguer P. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: Relevance to ADOA pathogenesis. J Cell Physiol 2007;211:423-30. (IF: 4.3)
    • • Pénisson-Besnier I, Biancalana V, Reynier P, Cossée M, Dubas F. Diagnosis of myotubular myopathy in the oldest known manifesting female carrier: a clinical and genetic study. Neuromuscul Disord 2007;17:180-85.(IF: 2.9)
    • • Loiseau D, Chevrollier A, Verny C, Guillet V, Gueguen N, Pou de Crescenzo MA, Ferré M, Malinge MC, Guichet A, Nicolas G, Amati-Bonneau P, Malthièry Y, Bonneau D, Reynier P. Mitochondrial Coupling Defect in Charcot-Marie-Tooth Type 2A Disease. Ann Neurol 2007;61:315-23. (IF: 9.9)
    • • Lévêque M, Marlin S, Jonard L, Procaccio V, Reynier P, Amati-Bonneau P, Baulande S, Pierron D, Lacombe D, Duriez F, Francannet C, Mom T, Journel H, Catros H, Drouin-Garraud V, Obstoy MF, Dollfus H, Eliot MM, Faivre L, Duvillard C, Couderd R, Garabedian EN, Petit C, Feldmann D and Denoyelle F. Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip. Eur J Hum Genet 2007;15:1145-55. (IF: 3.9)
    • • Moal V, Mathieu E, Reynier P, Malthièry Y, Gallois Y. Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques. Clin Chim Acta2007;386:12-19. (IF: 2.9)
    • • Stoetzel C, Muller J, Laurier V, Davies EE, Zaghloul NA, Vicaire S, Jacquelin C, Plewniak F, Leitch CC, Sarda P, Hamel C, de Ravel TJL, Lewis RA, Thibault C, Danse JM, Verloes A, Bonneau D, Katsanis N, Poch O, mandel JL, Dollfus H. Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am J Hum Genet 2007;80:1-11. (IF: 10.1)
    • • Clewing JM, Fryssira H, Goodman D, Smithson SF, Sloan EA, Lou S, Huang Y, Choi K, Lucke T, Alpay H, Andre JL, Asakura Y, Biebuyck-Gouge N, Bogdanovic R, Bonneau D, Cancrini C, Cochat P, Cockfield S, Collard L, Cordeiro I, Cormier-Daire V, Cransberg K, Cutka K, Deschenes G, Ehrich JH, Frund S, Georgaki H, Guillen-Navarro E, Hinkelmann B, Kanariou M, Kasap B, Kilic SS, Lama G, Lamfers P, Loirat C, Majore S, Milford D, Morin D, Ozdemir N, Pontz BF, Proesmans W, Psoni S, Reichenbach H, Reif S, Rusu C, Saraiva JM, Sakallioglu O, Schmidt B, Shoemaker L, Sigaudy S, Smith G, Sotsiou F, Stajic N, Stein A, Stray-Pedersen A, Taha D, Taque S, Tizard J, Tsimaratos M, Wong NA, Boerkoel CF. Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat 2007;28:273-283. (IF: 7)
    • • Saugier-Veber P, Bonnet C, Afenjar A, Drouin-Garraud V, Coubes C, Fehrenbach S, Holder-Espinasse M, Roume J, Malan V, Portnoi MF, Jeanne N, Baumann C, Héron D, David A, Gérard M, Bonneau D, Lacombe D, Cormier-Daire V, Billette de Villemeur T, Frébourg T, Bürglen L. Heterogenity of NSD1 alterations in 116 patients with Sotos syndrome. Hum Mutat2007;28:1098-1107. (IF: 7)
    • • Bouchet C, Gonzales M, Vuillaumier-Barrot S, Devisme L, Lebizec C, Alanio E, Bazin C, Bessières-Grattagliano B, Bigi N, Blanchet P, Bonneau D, Bonnières M, Carles D, Delahaye S,Fallet-Bianco C, Figarella-Branger D, GaillarD, Gasser B, Guimiot F, Joubert M, Laurent N, Liprandi A, Loget P, Marcorelles P, Martinovic J, Menez F, Patrier S,Pelluard-Nehmé F, Perez MJ, Rouleau-Dubois C, Triau S, Laquerrière A, Encha-Razavi F, Seta N.. Molecular Heterogeneity in Fetal Forms of type II Lissencephaly. Hum Mutat 2007;28:1020-1027. (IF: 7)
    • • Marchant D, Yu K, Bigot K, Roche O, Germain A, Bonneau D, Drouin-Garraud V, Schorderet D, Munier F, Schmidt D, Le Neindre P, Marsac C, Menasche M, Dufier JL, Fischmeister R, Hartzell C, Abitbol M. New VMD2 gene mutations identified in patients affected by Best Vitelliform. Macular Dystrophy. J Med Genet 2007;44:e70.(IF: 5,7)
    • • Verny C, Allain P, Prudean A, Malinge MC, Gohier B, Scherer C, Bonneau D, Dubas F, Le Gall D. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol 2007;14:1344-1350. (IF: 2.7)
    • • Gaillard C, Alix E, Sallé A, Berrut G, Ritz P. Energy requirements in frail elderly people: a review of the literature. Clin Nutr 2007;26:16-24. (IF: 3.2)
    • • Ritz P, Sallé A, Audran M, Rohmer V. Comparison of different methods to assess body composition of weight loss in obese and diabetic patients. Diabetes Res Clin Pract 2007;77: 405-411. (IF: 1.9)
    • • Alix E, Berrut G, Boré M, Bouthier-Quintard F, Buia JM, Chlala A, Cledat Y, d'Orsay G, Lavigne C, Levasseur R, Mouzet JB, Ombredanne MP, Sallé A, Gaillard C, Ritz P. Energy requirements in hospitalized elderly people. J Am Geriatr Soc 2007;55:1085-1089. (IF: 3.8)
    • • Ritz P, Prod’homme F, Berger V, Piquet M, Sallé A, Berrut G. Nutritional Risk Score is not sensitive enough to predict weight loss in diseased elderly subjects. J Nutr Health Aging 2007;11:389-392. (IF: 2.3)
    • • Baux D, Larrieu L, Blanchet C, Hamel C, Ben Salah B, Vielle A, Gilbert B, Holder M, Calvas P, Philip N, Edery P, Bonneau D, Claustres M, Malcom S, Roux AF. Molecular and in silico analyses of the full length isoform of usherin identify new pathogenic alleles in Usher type II patients. Hum Mutat 2007;28:781-789. (IF: 7)
    • • Belizna CC, Richard V, Thuillez C, Lévesque H, Shoenfeld Y. Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev. 2007 ;7:46-51. (IF:5.371)
    • • Belizna CC, Richard V, Thuillez C, Lévesque H, Shoenfeld Y. Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev. 2007 ;7:46-51. (IF:5.371)

    2006

    • • Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, Lee DC, Coffman TM, Richard S, Dussaule JC, Tharaux PL. Heparin binding EGF is necessary for vasospastic response to endothelin. FASEB J. 2006;20:1936-1938. (IF:7.1)
    • • Mercier N, Osborne-Pellegrin M, El Hadri K, Kakou A, Labat C, Loufrani L, Henrion D, Challande P, Jalkanen S, Feve B, Lacolley P. Carotid arterial stiffness, elastic fibre network and vasoreactivity in semicarbazide-sensitive amine-oxidase null mouse. Cardiovasc Res. 2006;72:349-357. (IF:5.9)
    • • Belin de Chantemèle E, Gauquelin-Koch G, Duvareille M, Pellet N, Gharib C, Custaud MA. Blood volume measurement: The comparison of pulse dye densitometry and Dill and Costill's methods. Life Sci. 2006;78:1564-9. (IF:2.6)
    • • Dessaud E, Salaün D, Gayet O, Chabbert M. deLapeyrière O. Identification of Lynx2: a novel Ly-6/neurotoxin superfamily member expressed in distinct neuronal subpopulations during mouse development.Mol. Cell. Neurosci., 2006 ;31:232-42. (IF:3.9)
    • • Grouiller F, Jaquinandi V, Picquet J, Souday V, Saumet JL, Abraham P. Validation of a new device for transcutaneous oxygen pressure recordings in real and simulated exercise tests. Int Angiol 2006;25(2):190-6.(IF:1.4)
    • • Demiot C, Tartas M, Fromy B, Abraham P, Saumet JL, Sigaudo-Roussel D. Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic neuropathy. Diabetes 2006;55:1478-83. (IF:8.4)
    • • Le Faucheur A, Desvaux BN, Bouye P, Jaquinandi V, Saumet JL, Abraham P. The physiological response of ankle systolic blood pressure and ankle to brachial index after maximal exercise in athletes is dependent on age.Eur J Appl Physiol 2006;96:505-10. (IF:1.9)
    • • Schang D, Bellard E, Plantier G, Dupuis JM, Victor J, Leftheriotis G. Comparison of computational algorithms applied on transthoracic impedance waveforms to predict head-up tilt table testing outcome.Comput Biol Med2006;36(3):225-40. (IF:1.2)
    • • Gagnadoux F, Meslier N, Svab I, Menei P, Racineux JL. Sleep-disordered breathing in patients with Chiari malformation: improvement after surgery. Neurology 2006;66:136-8. (IF:7.0)
    • • Gagnadoux F, Leblond V, Vecellio L, Hureaux J, Le Pape A, Boisdron-Celle M, Montharu J, Majoral C, Fournier J, Urban T, Diot P, Racineux JL, Lemarie E. Gemcitabine aerosol: in vitro antitumor activity and deposition imaging for preclinical safety assessment in baboons. Cancer Chemother Pharmacol 2006;58(2):237-44.(IF:2.7)
    • • Cattan D, Bouali B, Chassaing N, Martinez F, Dupont JM, Dode C, Martin L. Early and severe amyloidosis in a patient with concurrent familial Mediterranean fever and pseudoxanthoma elasticum. Br J Dermatol2006;154(6):1190-3. (IF:3.5)
    • • Le Saux O, Bunda S, VanWart CM, Douet V, Got L, Martin L, Hinek A. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J Invest Dermatol 2006;126(7):1497-505.(IF:5.2)
    • • Nguyen LD, Terbah M, Daudon P, Martin L. Left ventricular systolic and diastolic function by echocardiogram in pseudoxanthoma elasticum. Am J Cardiol 2006;97:1535-7. (IF:3.9)
    • • Volodko NV, L’vova MA, E. B. Starikovskaya, Derbeneva OA, Bychkov IY, Mikhailovskaya IE, Pogozheva IV, Fedotov FF, Soyan GV, Procaccio V, Wallace DC, Sukernik R. Spectrum of Pathogenic mtDNA Mutations in Leber’s Hereditary Optic Neuropathy Families from Siberia Genetika (2006) 42: 76-83. (IF:1.8)
    • • Duckles S, Krause D, Stirone C, Procaccio V. Estrogen and Mitochondria: A New Paradigm for Vascular Protection? Molecular Interventions (2006) 6: 26-35. (IF:8.3)
    • • Naïmi M, Bannwarth S, Procaccio V, Pouget J, Desnuelle C, Pellissier JF, Rötig A, Munnich A, Richelme C, Jonveaux P, Castelnovo G, Calvas P, Simon M, Wallace DC, Paquis-Flucklinger V. Molecular analysis of SLC25A4, TWINKLE and POLG in Patients With Multiple Deletions or Depletion of Mitochondrial DNA by a DHPLC-based assay. European Journal of Human Genetics (2006) 14: 917-922.(IF:3.9)
    • • Mishmar D, Ruiz-Pesini E, Mondragon-Palomino M, Procaccio V, Gaut B, Wallace DC. Phases of adaptive evolution in primate OXPHOS complex I shed light on the complex structure. Gene (2006) 378:11-8.(IF:2.6)
    • • Procaccio V, Salazar G, Ono S, Styers M, Gearing M, Davila A, Jimenez R, Juncos J, Gutekunst CA, Meroni G, Fontanella B, Sontag E, J Sontag JM, Faundez V, Wainer BH. A mutation of β-actin which alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness and dystonia. American Journal of Human Genetics (2006) 78:947-960. (IF:10.1)
    • • Kleim J, Chan S, Pringle E, Schallert K, Procaccio V, Jimenez R, Cramer S. BDNF val66/met polymorphism is associated with impaired experience-dependent plasticity in human motor cortex. Nature Neuroscience(2006) 6: 735-737. (IF:14.1)
    • • Bannwarth S, Procaccio V, Paquis-Flucklinger V. Rapid identification of unknown heteroplasmic mtDNA mutations across the entire human mitochondrial genome with mismatch-specific Surveyor Nuclease. Nature Protocols(2006) 1:2037-2047. (IF:4.2)
    • • Procaccio V, Neckelmann N, Paquis-Flucklinger V, Bannwarth S, Jimenez R, Davila A, Poole J and WallaceDC.Detection of Low Levels of the tRNAleu(UUR) 3243A>G Mutation in Mitochondrial DNA in Blood Derived from Patients with Diabetes. Molecular Diagnosis and Therapy (2006) 6: 381-389. (IF:2.1)
    • • Rezzani R, Rodella LF, Tengattini S, Bonomini F, Pechánová O, Kojsová S, Andriantsitohaina R, Bianchi R. Protective role of polyphenols in cyclosporine A-induced nephrotoxicity during rat pregnancy. J Histochem Cytochem. 2006;54(8):923-32. (IF: 2.8)
    • • Loichot C, Jesel L, Tesse A, Tabernero A, Schoonjans K, Roul G, Carpusca I, Auwerx J, Andriantsitohaina R. Deletion of peroxisome proliferator-activated receptor-alpha induces an alteration of cardiac functions. Am J Physiol. 2006;291(1):H161-6. (IF:3.6)
    • • Babál P, Kristová V, Cerná A, Janega P, Pechánová O, Danihel L, Andriantsitohaina R. Red wine polyphenols prevent endothelial damage induced by CCl4 administration. Physiol Res. 2006;55(3):245-51.(IF:1.6)
    • • Meziani F, Tesse A, David E, Martinez MC, Wangesteen R, Schneider F,Andriantsitohaina R. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol. 2006;169:1473-83. (IF:5.7)
    • • Púzserová A, Csizmadiová Z, Andriantsitohaina R, Bernátová I. Vascular effects of red wine polyphenols in chronic stress-exposed Wistar-Kyoto rats. Physiol Res. 2006;55 Suppl 1:S39-47. (IF:1.6)
    • • Jendeková L, Kojsová S, Andriantsitohaina R, Pechánová O. The time-dependent effect of red wine Provinols on brain NO synthase activity in L-NAME-induced hypertension. Physiol Res. 2006;55 Suppl 1:S31-7.(IF:1.6)
    • • A, Diouf B, Guérineau NC, Quittau-Prévostel C, Peter M, Coudane F, Hollande F, Joubert D. A spatiotemporally coordinated cascade of protein kinase C activation controls isoform-selective translocation. Mol Cell Biol.2006;26:2247-2261. (IF:6.1)
    • • Claes, C, Milea, D, Bodaghi, B, Tran, T.H., LeHoang, P., Blanc, R., 2006. Acute retrobulbar optic neuropathy due to rupture of an anterior communicating artery aneurysm. Acta Ophthalmol Scand 84, 145-146. (IF:1.9)
    • • Bangsgaard, R., Larsen, V.A., Milea, D., 2006. Isolated bilateral optic neuritis in acute disseminated encephalomyelitis. Acta Ophthalmol Scand 84, 815-817. (IF:1.9)
    • • Dupas, B., Milea, D., Sourour, N., LeHoang, P., 2006. First a third, then a fourth nerve palsy in multiple intracranial aneurysms. Graefes Arch Clin Exp Ophthalmol 244, 1539-1541. (IF:1.77)
    • • Bouhours-Nouet N, Boux de Casson F, Rouleau S, Douay O, Mathieu E, Bouderlique C, Gillard P, Limal JM, Descamps P, Coutant R: Maternal and cord blood ghrelin in the pregnancies of smoking mothers: possible markers of nutrient availability for the fetus. Horm Res 66:6-12, 2006 (IF:2.285)
    • • Gloyn AL, Diatloff-Zito C, Edghill EL, Bellanne-Chantelot C, Nivot S, Coutant R, Ellard S, Hattersley AT, Robert JJ: KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 14:824-830, 2006 (IF:3.925)
    • • Limal JM, Bouhours-Nouet N, Rouleau S, Gatelais F, Coutant R: [Acute adrenal insufficiency in the newborn]. Arch Pediatr 13:1358-1363, 2006 (IF:0.356)
    • • Hazard I, Bouhours-Nouet N, Baron S, Ramos E, Gatelais F, Coutant R: Birthweight predicts insulin requirements in children and adolescents with Type 1 diabetes. Diabet Med 23:1273-1274, 2006 (IF:3.172)
    • • Rey RA, Venara M, Coutant R, Trabut JB, Rouleau S, Lahlou N, Sultan C, Limal JM, Picard JY, Lumbroso S: Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Hum Mol Genet 15:3538-3543, 2006 (IF:7.249)
    • • Dufresne S, Bellanger S, Bouhours-Nouet N, Akhdar M, Py I, Gatelais F, Coutant R: [Group therapy versus individual follow-up in the management of the obese child]. Arch Pediatr 13 Suppl 1:S62-66, 2006(IF:0.356)
    • • Toulemonde A, Croue A, Rodien P, Verret JL. Malignant nodular hidradenoma and multiple nodular hidradenomas in a hypogonadic patient. Ann Dermatol Venereol. 2006 Dec;133(12):1005-8. (IF:0.482)
    • • Illouz F, Dubois-Ginouves S, Laboureau S, Rohmer V, Rodien P. [Use of cabergoline in persisting Cushing's disease. Ann Endocrinol (Paris). 2006 Sep;67(4):353-6. (IF:0.446)
    • • Briet M., Bozec E., Laurent S., Fassot C., London G.M., Jacquot C., Froissart M., Houillier P., Boutouyrie P. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney International, 2006 ; 69:350-7. (IF:6.418)
    • • Jacques C, Chevrollier A, Loiseau D, Lagoutte L, Savagner F, Malthièry Y, Reynier P. MtDNA controls expression of the Death Associated Protein 3. Exp Cell Res 2006;312:737-45. (IF:3.9)
    • • Reynier P et le réseau "Maladies Mitochondriales". Epidemiology of mitochondrial cytopathies: contribution from the French mitochondrial diseases network. Ann Biol Clin (Paris) 2006;64:584-86. French.(IF:0.3)
    • • Stoetzel C, Laurier V, Davies E, Muller J, Rix S, Badano L, Leitch C, Salem N, Chouery E, Corbani S, Jalk N, Vicaire S, Sarda P, Hamel C, Lacombe D, Holder M, Odent S, Holder S, Brooks AS, Elcioglu NH, Da Silva E, Rossillion B, Sigaudy S, de Ravel TJL, Lewis RA, Leheup B, Verloes A, Amati-Bonneau P, Mégarbane A, Poch O, Bonneau D, Beales PL, Mandel JL, Katsanis N, Dollfus H. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet 2006;38:521-4. (IF:30.2)
    • • Laurier V, Stoetzel C, Muller J, Thibault C, Corbani S, Jalkh N, Nabiha S, Chouery E, Poch O, Danse JM, Amati-Bonneau P, Bonneau D, Mégarbané A, Mandel JL, Dollfus H. Pitfalls of homozygosity mapping; an extanded consanguineous Bardet-Biedl syndrome family with two mutant genes (BBS2, BBS10), three mutations but no triallelism. Eur J Hum Genet 2006;14:1195-1203. (IF:3.9)
    • • Niihori T, Aoki Y, Narumi Y, Neri G, Cavé H, Verloe A, Okamoto N, Hennekam RCM, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Héron D, Bonneau D, Corona G, Kaname T, Naritomi K, Bauman C, Matsumoto N, Kato K, Kure S, Masubara Y. Germline KRAS and BRAF mutations in cardio-facio-cutaneous (CFC) syndrome. Nat Genet 2006;38:294-296. (IF:30.2)
    • • Gerber S, Bonneau D, Gilbert B, Munnich A, Dufier JL, Rozet JM, Kaplan J. USH1A: Chronicle of a slow death. Am J Hum Genet 2006;78:357-359. (IF:10.1)
    • • Verny C, Prundean A, Nicolas G, Pautot V, Levade T, Dubas F, Bonneau B. Refsum disease may mimick familial Guillain Barré syndrome. Neuromuscul Disord 2006;16:805-808. (IF:2.9)
    • • Stoetzel C, Laurier V, Faivre L, Megarbane A, Perrin-Schmitt F, Verloes A, Bonneau D, Mandel JL, Cossee M, Dollfus H. BBS8 is rarely mutated in a cohort of 128 Bardet-Biedl syndrome families. J Hum Genet2006;51:81-84. (IF:2.4)
    • • Desquiret V, Loiseau D, Jacques C, Douay O, Malthièry Y, Ritz P, Roussel D. Dinitrophenol-induced mitochondrial uncoupling in vivo triggers respiratory adaptation in HepG2 cells. Biochim Biophys Acta2006;1757:21-30 (IF :4.4)
    • • Ryan M, Sallé A, Guilloteau G, Genaitay M, Livingstone MBE, Ritz P. Resting energy expenditure is not increased in obese type-2 diabetic patients. Br J Nutr 2006;96:945-948. (IF:2.8)
    • • Sallé A, Ryan M, Ritz P. Underreporting of food intake in obese diabetic and nondiabetic patients. Diabetes Care; 2006;29:2726-2727. (IF:7.3)
    • • Cabrejo L, Guyant-Marechal L, Laquerriere A, Vercelletto M, De la Fourniere F, Thomas-Anterion C, Verny C, Letournel F, Pasquier F, Vital A, Checler F, Frebourg T, Campion D, Hannequin D. Phenotype associated with APP duplication in five families. Brain 2006;129:2966-76. (IF:9.6)
    • • Lanctin C, Wiertlewski S, Moreau C, Verny C, Derkinderen P, Damier P, Dubas F. Idiopathic acute transverse myelitis: application of new diagnosis criteria to 17 patients. Rev Neurol (Paris) 2006;162:980-9.(IF:0.5)
    • • Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi, Hantraye P Remy P Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006;32:1562-75. (IF:5.7)
    • • Azzedine H Ravise N Verny C, Gabreels-Festen A, Lammens M, Grid D, Vallat JM, Durosier G, Senderek J, Nouioua S, Hamadouche T, Bouhouche A, Guilbot A, Stendel C, Ruberg M, Brice A, Birouk N, Dubourg O, Tazir M, LeGuern E. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology2006;67:602-6. (IF:7.0)
    • • Dubourg O, Azzedine H, Verny C, Durosier G, Birouk N, Gouider R, Salih M, Bouhouche A, Thiam A, Grid D, Mayer M, Ruberg M, Tazir M, Brice A, LeGuern E. Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med 2006;8:75-86. (IF:2.6)